10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from  to  

Commission File Number 1-13397

Ingredion Incorporated

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation or organization)

22-3514823

(I.R.S. Employer Identification Number)

5 Westbrook Corporate Center Westchester, Illinois	60154
(Address of principal executive offices)	(Zip Code)

(708) 551-2600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value per share	INGR	New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

Class	Outstanding at July 31, 2020
Common Stock, $.01 par value	66,987,048 shares

INGREDION INCORPORATED

FORM 10-Q

TABLE OF CONTENTS

		Page
Part I
Item 1	Financial Statements	3
	Condensed Consolidated Statements of Income	3
	Condensed Consolidated Statements of Comprehensive (Loss) Income	4
	Condensed Consolidated Balance Sheets	5
	Condensed Consolidated Statements of Equity and Redeemable Equity	6
	Condensed Consolidated Statements of Cash Flows	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2	Management’s discussion and analysis of financial condition and results of operations	25
Item 3	Quantitative and qualitative disclosures about market risk	35
Item 4	Controls and procedures	35
Part II
Item 1	Legal proceedings	36
Item 1A	Risk factors	36
Item 2	Unregistered sales of equity securities and use of proceeds	36
Item 6	Exhibits	37
Signatures		38

2

PART I FINANCIAL INFORMATION

ITEM 1

FINANCIAL STATEMENTS

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of Income

(Unaudited)

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions, except per share amounts)	2020		2019		2020		2019
Net sales	$	1,349	$	1,550	$	2,892	$	3,086
Cost of sales		1,078		1,221		2,298		2,441
Gross profit		271		329		594		645
Operating expenses		147		154		301		304
Other income, net		—		(2)		2		(1)
Restructuring/impairment charges		11		9		25		13
Operating income		113		168		266		329
Financing costs, net		19		16		37		38
Other, non-operating income, net		—		—		(1)		—
Income before income taxes		94		152		230		291
Provision for income taxes		27		45		85		82
Net income		67		107		145		209
Less: Net income attributable to non-controlling interests		1		2		4		4
Net income attributable to Ingredion	$	66	$	105	$	141	$	205
Weighted average common shares outstanding:
Basic		67.2		66.9		67.2		66.9
Diluted		67.6		67.4		67.7		67.4
Earnings per common share of Ingredion:
Basic	$	0.98	$	1.57	$	2.10	$	3.06
Diluted	$	0.98	$	1.56	$	2.08	$	3.04

See Notes to Condensed Consolidated Financial Statements

3

PART I FINANCIAL INFORMATION

ITEM 1

FINANCIAL STATEMENTS

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Net income	$	67	$	107	$	145	$	209
Other comprehensive income (loss):
(Losses) gains on cash flow hedges, net of income tax effect of $4, $3, $16 and $ — , respectively		(16)		10		(50)		1
Losses on cash flow hedges reclassified to earnings, net of income tax effect of $4, $1, $6 and $1, respectively		15		3		19		5
Actuarial losses on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect of $ —		—		(1)		—		(1)
Currency translation adjustment		16		(4)		(118)		(3)
Comprehensive income (loss)		82		115		(4)		211
Less: Comprehensive income (loss) attributable to non-controlling interests		2		(2)		2		—
Comprehensive income (loss) attributable to Ingredion	$	80	$	117	$	(6)	$	211

See Notes to Condensed Consolidated Financial Statements

4

PART I FINANCIAL INFORMATION

ITEM 1

FINANCIAL STATEMENTS

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Balance Sheets

	June 30,		December 31,
(in millions, except share and per share amounts)	2020		2019
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	1,047	$	264
Short-term investments		1		4
Accounts receivable, net		861		977
Inventories		859		861
Prepaid expenses		52		54
Total current assets		2,820		2,160
Property, plant and equipment, net of accumulated depreciation of $3,039 and $3,056, respectively		2,231		2,306
Goodwill		791		801
Other intangible assets, net of accumulated amortization of $210 and $197, respectively		421		437
Operating lease assets		149		151
Deferred income tax assets		17		13
Other assets		182		172
Total assets	$	6,611	$	6,040
Liabilities and equity
Current liabilities:
Short-term borrowings	$	470	$	82
Accounts payable and accrued liabilities		812		885
Total current liabilities		1,282		967
Non-current liabilities		209		220
Long-term debt		2,140		1,766
Non-current operating lease liabilities		115		120
Deferred income tax liabilities		172		195
Share-based payments subject to redemption		27		31
Ingredion stockholders’ equity:
Preferred stock — authorized 25,000,000 shares — $0.01 par value, none issued		—		—
Common stock — authorized 200,000,000 shares — $0.01 par value, 77,810,875 issued at June 30, 2020 and December 31, 2019, respectively		1		1
Additional paid-in capital		1,143		1,137
Less: Treasury stock (common stock: 10,825,142 and 10,993,388 shares at June 30, 2020 and December 31, 2019, respectively) at cost		(1,027)		(1,040)
Accumulated other comprehensive loss		(1,307)		(1,158)
Retained earnings		3,836		3,780
Total Ingredion stockholders’ equity		2,646		2,720
Non-controlling interests		20		21
Total equity		2,666		2,741
Total liabilities and equity	$	6,611	$	6,040

See Notes to Condensed Consolidated Financial Statements

5

PART I FINANCIAL INFORMATION

ITEM 1

FINANCIAL STATEMENTS

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of Equity and Redeemable Equity

(Unaudited)

	Total Equity														Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2019	$	—	$	1	$	1,137	$	(1,040)	$	(1,158)	$	3,780	$	21	$	31
Net income attributable to Ingredion												141
Net income attributable to non-controlling interests														4
Dividends declared												(85)		(3)
Share-based compensation, net of issuance						6		13								(4)
Other comprehensive loss										(149)				(2)
Balance, June 30, 2020	$	—	$	1	$	1,143	$	(1,027)	$	(1,307)	$	3,836	$	20	$	27

			Total Equity												Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2018	$	—	$	1	$	1,096	$	(1,091)	$	(1,154)	$	3,536	$	20	$	37
Net income attributable to Ingredion												205
Net income attributable to non-controlling interests														4
Dividends declared												(85)		(4)
Repurchases of common stock						32		31
Share-based compensation, net of issuance						10		13								(12)
Other comprehensive income (loss)										2				(4)
Balance, June 30, 2019	$	—	$	1	$	1,138	$	(1,047)	$	(1,152)	$	3,656	$	16	$	25

See Notes to Condensed Consolidated Financial Statements

6

PART I FINANCIAL INFORMATION

ITEM 1

FINANCIAL STATEMENTS

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended
	June 30,
(in millions)	2020		2019
Cash provided by operating activities
Net income	$	145	$	209
Non-cash charges to net income:
Depreciation and amortization		106		103
Mechanical stores expense		26		28
Deferred income taxes		(2)		10
Other		25		33
Changes in working capital:
Accounts receivable and prepaid expenses		64		(65)
Inventories		(31)		(39)
Accounts payable and accrued liabilities		(21)		(32)
Margin accounts		(18)		15
Other		—		(9)
Cash provided by operating activities		294		253
Cash used for investing activities
Capital expenditures and mechanical stores purchases, net of proceeds on disposals		(175)		(156)
Payments for acquisitions, net of cash acquired of $ — and $4, respectively		—		(42)
Investment in non-consolidated affiliates		(6)		(10)
Short-term investments		3		3
Cash used for investing activities		(178)		(205)
Cash provided by (used for) financing activities
Proceeds from borrowings		1,486		714
Payments on debt		(709)		(765)
Payments for debt issuance costs		(9)		—
Repurchases of common stock, net		—		63
Issuances of common stock for share-based compensation, net of settlements		2		—
Dividends paid, including to non-controlling interests		(87)		(87)
Cash provided by (used for) financing activities		683		(75)
Effects of foreign exchange rate changes on cash		(16)		(3)
Increase (decrease) in cash and cash equivalents		783		(30)
Cash and cash equivalents, beginning of period		264		327
Cash and cash equivalents, end of period	$	1,047	$	297

See Notes to Condensed Consolidated Financial Statements

7

INGREDION INCORPORATED (“Ingredion”)

Notes to Condensed Consolidated Financial Statements

1. Interim Financial Statements

References to the “Company” are to Ingredion Incorporated (“Ingredion”) and its consolidated subsidiaries. These statements should be read in conjunction with the consolidated financial statements and the related notes to those statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

The unaudited Condensed Consolidated Financial Statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and 2019 included herein were prepared by management on the same basis as the Company’s audited Consolidated Financial Statements for the year ended December 31, 2019 and reflect all adjustments (consisting solely of normal recurring items unless otherwise noted) which are, in the opinion of management, necessary for the fair presentation of the Condensed Consolidated Statements of Income, Condensed Consolidated Statements of Comprehensive Income (Loss), Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows. The results for the interim period are not necessarily indicative of the results expected for the full year.

2.     Summary of Significant Accounting Standards and Policies

For detailed information about the Company’s significant accounting standards, see Note 2 of the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Except for the matters discussed below, there have been no other material changes to the Company’s significant accounting policies for the three and six months ended June 30, 2020.

Recently Adopted Accounting Standards

ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350)

In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This Update simplifies the subsequent measurement of goodwill as the Update eliminates Step 2 from the goodwill impairment test. Under the Update, an entity will continue to perform its annual, or interim, goodwill impairment test to determine if the fair value of a reporting unit is greater than its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value using the results of its Step 1 assessment, with the loss recognized not to exceed the total amount of goodwill allocated to that reporting unit. This Update is effective for annual periods beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU 2017-04 at the beginning of its 2020 fiscal year and the Update did not have a material impact on the Company’s Condensed Consolidated Financial Statements upon adoption.

ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326)

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. This Update is effective for annual periods beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU 2016-13 at the beginning of its 2020 fiscal year and the Update did not have a material impact on the Company’s Condensed Consolidated Financial Statements upon adoption.

Net Sales Presentation Change

During the three months ended December 31, 2019, the Company changed its presentation of shipping and handling costs.  These expenses were previously included as a reduction to Net sales in the Condensed Consolidated Statements of Income.  The Company is now presenting these expenses within Cost of sales in the Condensed Consolidated Statements of Income.  The change in presentation was applied retrospectively to all periods presented in the Condensed Consolidated Statements of Income.  The change in presentation had no effect on Gross profit, Operating income, Net income, or Earnings per share.  The Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of

8

Comprehensive Income (Loss), Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows are not affected by this change in presentation.

The effect of the adjustment is as follows:

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Consolidated Statements of Income:
Net sales before shipping and handling costs	$	1,550	$	—	$	3,086	$	—
Less: shipping and handling costs		116		—		232		—
Net sales		1,434		1,550		2,854		3,086
Cost of sales		1,105		1,221		2,209		2,441
Gross profit	$	329	$	329	$	645	$	645

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Net sales to unaffiliated customers:
North America	$	885	$	977	$	1,745	$	1,928
South America		215		226		433		454
Asia-Pacific		195		203		389		406
EMEA		139		144		287		298
Total	$	1,434	$	1,550	$	2,854	$	3,086

3. Acquisitions

On March 1, 2019, the Company completed its acquisition of Western Polymer LLC (“Western Polymer”), a privately-held, U.S.-based company headquartered in Moses Lake, Washington, that produces native and modified potato starches for industrial and food applications for $42 million, net of cash acquired of $4 million. The acquisition will expand the Company's potato starch manufacturing capacity, enhance processing capabilities, and broaden its higher-value specialty ingredients business and customer base. The results of the acquired operation are included in the Company’s consolidated results from the acquisition date forward within the North America business segment.

During the three months ended March 31, 2020, the Company finalized the purchase price allocation for the Western Polymer acquisition. The finalization of goodwill and intangible assets did not have a significant impact on previously estimated amounts. The acquisition of Western Polymer added $13 million of goodwill and intangible assets and $29 million of net tangible assets as of the acquisition date.

Goodwill represents the amount by which the purchase price exceeds the estimated fair value of the net assets acquired. The goodwill results from synergies and other operational benefits expected to be derived from the acquisition. The goodwill related to Western Polymer is tax-deductible due to the structure of the acquisition.

Pro-forma results of operations for the acquisition made in 2019 have not been presented as the effect of the acquisition would not be material to the Company’s results of operations for any periods presented.

4. Revenue Recognition

The Company applies the provisions of Accounting Standards Codification (“ASC”) 606-10, Revenue from Contracts with Customers. The Company recognizes revenue under the core principle to depict the transfer of products to customers in an amount reflecting the consideration the Company expects to receive. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

The Company identified customer purchase orders, which in some cases are governed by a master sales agreement, as the contracts with its customers. For each contract, the Company considers the transfer of products, each of which is distinct, to be the identified performance obligation. In determining the transaction price for the performance

9

obligation, the Company evaluates whether the price is subject to adjustment to determine the consideration to which the Company expects to be entitled. The pricing model can be fixed or variable within the contract. The variable pricing model is based on historical commodity pricing and is determinable prior to completion of the performance obligation. Additionally, the Company has certain sales adjustments for volume incentive discounts and other discount arrangements that reduce the transaction price. The reduction of the transaction price is estimated using the expected value method based on an analysis of historical volume incentives or discounts, over a period of time considered adequate to account for current pricing and business trends. Historically, actual volume incentives and discounts relative to those estimated and included when determining the transaction price have not materially differed. Volume incentives and discounts are accrued at the satisfaction of the performance obligation and accounted for in Accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheets. These amounts are not significant as of June 30, 2020 or December 31, 2019. The product price as specified in the contract, net of any discounts, is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Payment is received shortly after the performance obligation is satisfied; therefore, the Company has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component.

Revenue is recognized when the Company’s performance obligation is satisfied and control is transferred to the customer, which occurs at a point in time, either upon delivery to an agreed upon location or to the customer. Further, in determining whether control has transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer.

Shipping and handling activities related to contracts with customers represent fulfillment costs and are recorded in Cost of sales. Taxes assessed by governmental authorities and collected from customers are accounted for on a net basis and excluded from revenues.  The Company applies a practical expedient to expense costs to obtain a contract as incurred as most contracts are one year or less. These costs primarily include the Company’s internal sales force compensation. Under the terms of these programs, these are generally earned and the costs are recognized at the time the revenue is recognized.

From time to time, the Company may enter into long-term contracts with its customers. Historically, the contracts entered into by the Company do not result in significant contract assets or liabilities.  Any such arrangements are accounted for in Other assets or Accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheets.  There were no significant contract assets or liabilities as of June 30, 2020 or December 31, 2019.

The Company is principally engaged in the production and sale of starches and sweeteners for a wide range of industries, and is managed geographically on a regional basis. The Company’s operations are classified into four reportable business segments: North America, South America, Asia-Pacific and Europe, Middle East and Africa (“EMEA”).  The nature, amount, timing and uncertainty of the Company’s Net sales are managed by the Company primarily based on its geographic segments. Each region’s product sales are unique to each region and have unique risks.

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Net sales to unaffiliated customers:
North America	$	848	$	977	$	1,811	$	1,928
South America		182		226		419		454
Asia-Pacific		187		203		376		406
EMEA		132		144		286		298
Total net sales	$	1,349	$	1,550	$	2,892	$	3,086

5. Restructuring and Impairment Charges

For the three and six months ended June 30, 2020, the Company recorded a total of $11 million and $25 million of pre-tax restructuring charges, respectively, as part of the Cost Smart program. For the three months ended June 30, 2020, the Company recorded $6 million of pre-tax restructuring charges for its Cost Smart cost of sales program, including $3 million of asset write-offs and $1 million of other costs in relation to the closure of the Lane Cove, Australia production facility. During the three months ended June 30, 2020, the Company also recorded $1 million of accelerated depreciation and $1 million of employee-related severance, primarily in North America. For the six months ended June 30, 2020, the Company recorded $15 million of pre-tax restructuring charges for its Cost Smart cost of sales program, including $6

10

million of asset write-offs, $2 million of other costs, and $1 million of accelerated depreciation in relation to the closure of the Lane Cove, Australia production facility. The Company expects to incur $2 million of additional restructuring costs during the remainder of 2020 related to the Lane Cove production facility closure. During the six months ended June 30, 2020, the Company also recorded $4 million of accelerated depreciation, $1 million of employee-related severance, and $1 million of other costs, primarily in North America.

Additionally, the Company recorded pre-tax restructuring charges of $5 million and $10 million during the three and six months ended June 30, 2020, respectively, for its Cost Smart selling, general and administrative expense (“SG&A”) program. During the three months ended June 30, 2020, the Company recorded $5 million of pre-tax restructuring charges, consisting primarily of other costs, including professional services, in North America. During the six months ended June 30, 2020, the Company recorded pre-tax restructuring costs of $10 million primarily in North America, consisting of $8 million of other costs, including professional services, and $2 million of employee-related severance.

For the three and six months ended June 30, 2019, the Company recorded $9 million and $13 million of pre-tax restructuring charges, respectively.  For the three and six months ended June 30, 2019, the Company recorded $6 million and $9 million, respectively, of other costs, including professional services, and employee-related severance in the North America and South America segments as part of its Cost Smart SG&A program. This included $1 million and $2 million of other costs associated with the Finance Transformation initiative in Latin America for the three and six months ended June 30, 2019, respectively. Additionally, for the three and six months ended June 30, 2019, the Company recorded $3 million and $4 million, respectively, of other costs, including professional services, as part of the Cost Smart cost of sales program, including $1 million and $2 million, respectively, in relation to the prior year cessation of wet-milling at the Stockton, California plant.

A summary of the Company’s employee-related severance accrual as of June 30, 2020 is as follows (in millions):

Balance in severance accrual as of December 31, 2019	$	15
Cost Smart cost of sales and SG&A		3
Payments made to terminated employees		(9)
Foreign exchange translation		(1)
Balance in severance accrual as of June 30, 2020	$	8

Of the $8 million severance accrual as of June 30, 2020, $7 million is expected to be paid in the next 12 months.

As of June 30, 2020, the Company identified certain assets within the Stockton, California and Lane Cove, Australia locations that met the held for sale criteria. The Company expects to sell these assets at a fair value equal to or greater than the carrying value as of June 30, 2020, and did not record a gain or loss associated with the reclassification of these assets to held for sale for the six months ended June 30, 2020. The assets classified as held for sale are reflected in the Condensed Consolidated Balance Sheets as follows:

(in millions)		June 30, 2020		December 31, 2019
Other assets	$	13	$	—

6. Financial Instruments, Derivatives and Hedging Activities

The Company is exposed to market risk stemming from changes in commodity prices (primarily corn and natural gas), foreign currency exchange rates and interest rates. In the normal course of business, the Company actively manages its exposure to these market risks by entering into various hedging transactions, authorized under established policies that place controls on these activities. These transactions utilize exchange-traded derivatives or over-the-counter derivatives with investment grade counterparties. Derivative financial instruments currently used by the Company consist of commodity-related futures, options and swap contracts, foreign currency-related forward contracts, interest rate swaps, and treasury locks (“T-Locks”).

Commodity price hedging: The Company’s principal use of derivative financial instruments is to manage commodity price risk relating to anticipated purchases of corn and natural gas to be used in the manufacturing process, generally over the next 12 to 24 months. The Company maintains a commodity-price risk management strategy that uses derivative instruments to minimize significant, unanticipated earnings fluctuations caused by commodity-price volatility.

11

To manage price risk related to corn purchases primarily in North America, the Company uses corn futures and option contracts that trade on regulated commodity exchanges to lock-in corn costs associated with fixed-priced customer sales contracts. The Company also uses over-the-counter natural gas swaps in North America to hedge a portion of its natural gas usage. These derivative financial instruments limit the impact that volatility resulting from fluctuations in market prices will have on corn and natural gas purchases. The Company’s natural gas derivatives and the majority of its corn derivatives have been designated as cash flow hedging instruments.

The Company enters into certain corn derivative instruments that are not designated as hedging instruments as defined by ASC 815, Derivatives and Hedging. Therefore, the realized and unrealized gains and losses from these instruments are recognized in cost of sales during each accounting period. These derivative instruments also mitigate commodity price risk related to anticipated purchases of corn.

For commodity hedges designated as cash flow hedges, unrealized gains and losses associated with marking the commodity hedging contracts to market (fair value) are recorded as a component of other comprehensive income (“OCI”) and included in the equity section of the Condensed Consolidated Balance Sheets as part of Accumulated other comprehensive income (“AOCI”). These amounts are subsequently reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings, or in the month a hedge is determined to be ineffective. The Company assesses the effectiveness of a commodity hedge contract based on changes in the contract’s fair value. The changes in the market value of such contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in the price of the hedged items. Gains and losses from cash flow hedging instruments reclassified from AOCI to earnings are reported as Cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.

As of June 30, 2020, the Company had outstanding futures and option contracts that hedged the forecasted purchase of approximately 64 million bushels of corn. The Company had outstanding swap and option contracts that hedged the forecasted purchase of approximately 33 million mmbtu’s of natural gas at June 30, 2020.

Foreign currency hedging: Due to the Company’s global operations, including operations in many emerging markets, the Company is exposed to fluctuations in foreign currency exchange rates. As a result, the Company has exposure to translational foreign-exchange risk when the results of its foreign operations are translated to U.S. dollars and to transactional foreign-exchange risk when transactions not denominated in the functional currency are revalued. The Company’s foreign-exchange risk management strategy uses derivative financial instruments such as foreign currency forward contracts, swaps and options to manage its transactional foreign exchange risk. The Company enters into foreign currency derivative instruments that are designated as both cash flow hedging instruments as well as instruments not designated as hedging instruments as defined by ASC 815, Derivatives and Hedging, in order to mitigate transactional foreign-exchange risk. Gains and losses from derivative financial instruments not designated as hedging instruments are marked to market in earnings during each accounting period.

The Company hedges certain assets using foreign currency derivatives not designated as hedging instruments, which had a notional value of $590 million and $621 million as of June 30, 2020 and December 31, 2019, respectively. The Company also hedges certain liabilities using foreign currency derivatives not designated as hedging instruments, which had a notional value of $478 million and $356 million as of June 30, 2020 and December 31, 2019, respectively.  

The Company hedges certain assets using foreign currency cash flow hedging instruments, which had a notional value of $325 million and $374 million as of June 30, 2020 and December 31, 2019, respectively. The Company also hedges certain liability positions using foreign currency cash flow hedging instruments, which had a notional value of $460 million and $541 million as of June 30, 2020 and December 31, 2019, respectively.

Interest rate hedging: The Company assesses its exposure to variability in interest rates by identifying and monitoring changes in interest rates that may adversely impact future cash flows and the fair value of existing debt instruments, and by evaluating hedging opportunities. The Company’s risk management strategy is to monitor interest rate risk attributable to both the Company’s outstanding and forecasted debt obligations as well as the Company’s offsetting hedge positions. Derivative financial instruments that have been used by the Company to manage its interest rate risk consist of interest rate swaps and T-Locks.

The Company periodically enters into interest rate swaps to hedge its exposure to interest rate changes. The changes in fair value of interest rate swaps designated as hedging instruments that effectively offset the variability in the

12

fair value of outstanding debt obligations are reported in earnings. These amounts offset the gains or losses (the changes in fair value) of the hedged debt instruments that are attributable to changes in interest rates (the hedged risk), which are also recognized in earnings. As of June 30, 2020, the Company did not have any outstanding interest rate swaps. As of December 31, 2019, the Company had an outstanding interest rate swap agreement that converted the interest rates on $200 million of its $400 million 4.625% senior notes due November 1, 2020, to variable rates.

The Company periodically enters into T-Locks to hedge its exposure to interest rate changes. The T-Locks are designated as hedges of the variability in cash flows associated with future interest payments caused by market fluctuations in the benchmark interest rate until the fixed interest rate is established, and are accounted for as cash flow hedges. Accordingly, changes in the fair value of the T-Locks are recorded to AOCI until the consummation of the underlying debt offering, at which time any realized gain (loss) is amortized to earnings over the life of the debt. The Company did not have outstanding T-locks as of June 30, 2020, or December 31, 2019.

The derivative instruments designated as cash flow hedges included in AOCI as of June 30, 2020 and December 31, 2019 are reflected below:

Derivatives in Cash Flow Hedging Relationships	Gains (Losses) included in AOCI
(in millions)	June 30, 2020		December 31, 2019
Commodity contracts, net of income tax effect of $13 and $5, respectively	$	(36)	$	(11)
Foreign currency contracts, net of income tax effect of $ — and $1, respectively		—		3
Interest rate contracts, net of income tax effect of $1 and $ — , respectively		(4)		(1)
Total	$	(40)	$	(9)

The fair value and balance sheet location of the Company’s derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are reflected below:

	Fair Value of Hedging Instruments as of June 30, 2020
	Designated Hedging Instruments (in millions)								Non-Designated Hedging Instruments (in millions)
Balance Sheet Location		Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total			Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total
Accounts receivable, net	$	3	$	—	$	—	$	3	$	—	$	5	$	—	$	5
Other assets		2		1		—		3		—		1		—		1
Assets		5		1		—		6		—		6		—		6
Accounts payable and accrued liabilities		26		2		—		28		4		16		—		20
Non-current liabilities		2		—		—		2		—		3		—		3
Liabilities		28		2		—		30		4		19		—		23
Net (Liabilities)/Assets	$	(23)	$	(1)	$	—	$	(24)	$	(4)	$	(13)	$	—	$	(17)

	Fair Value of Hedging Instruments as of December 31, 2019
	Designated Hedging Instruments (in millions)								Non-Designated Hedging Instruments (in millions)
Balance Sheet Location		Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total			Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total
Accounts receivable, net	$	5	$	7	$	—	$	12	$	2	$	4	$	—	$	6
Other assets		1		3		1		5		—		1		—		1
Assets		6		10		1		17		2		5		—		7
Accounts payable and accrued liabilities		13		4		—		17		1		8		—		9
Non-current liabilities		4		4		—		8		—		2		—		2
Liabilities		17		8		—		25		1		10		—		11
Net (Liabilities)/Assets	$	(11)	$	2	$	1	$	(8)	$	1	$	(5)	$	—	$	(4)

13

Additional information pertaining to the Company’s fair value hedges is presented below:

Line item in the statement of financial position in which the hedged item is included (in millions)	Carrying Amount of the Hedged Assets/(Liabilities)				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of Hedged Assets/(Liabilities)
Balance sheet date as of	June 30, 2020		December 31, 2019		June 30, 2020		December 31, 2019
Interest Rate Contracts:
Long-Term Debt	$	—	$	(201)	$	—	$	(1)

Additional information relating to the Company’s derivative instruments is presented below:

Derivatives in Cash Flow	Gains (Losses) Recognized  in OCI on Derivatives				Income	Gains (Losses) Reclassified from AOCI into Income
Hedging Relationships	Three Months Ended June 30,				Statement	Three Months Ended June 30,
(in millions)	2020		2019		Location	2020		2019
Commodity contracts	$	(20)	$	10	Cost of sales	$	(17)	$	(5)
Foreign currency contracts		1		3	Net sales/Cost of sales		(1)		1
Interest rate contracts		(1)		—	Financing costs, net		(1)		—
Total	$	(20)	$	13		$	(19)	$	(4)

Derivatives in Cash-Flow	Gains (Losses) Recognized  in OCI on Derivatives				Income	Gains (Losses) Reclassified from AOCI into Income
Hedging Relationships	Six Months Ended June 30,				Statement	Six Months Ended June 30,
(in millions, pre-tax)	2020		2019		Location	2020		2019
Commodity contracts	$	(57)	$	—	Cost of sales	$	(24)	$	(3)
Foreign currency contracts		(4)		1	Net sales/Cost of sales		—		(2)
Interest rate contracts		(5)		—	Financing costs, net		(1)		(1)
Total	$	(66)	$	1		$	(25)	$	(6)

Derivatives in Fair Value Hedging	Income Statement Location of	Gains (Losses) Recognized in Income				Income Statement	Gains (Losses) Recognized in Income
Relationships	Derivatives Designated as	Three Months Ended June 30,				Location	Three Months Ended June 30,
(in millions)	Hedging Instruments	2020		2019		of Hedged Items	2020		2019
Interest rate contracts	Financing costs, net	$	(4)	$	3	Financing costs, net	$	4	$	(3)

Derivatives in Fair Value	Income Statement Location of	Gains (Losses) Recognized in Income				Income Statement	Gains (Losses) Recognized in Income
Hedging Relationships	Derivatives Designated as	Six Months Ended June 30,				Location	Six Months Ended June 30,
(in millions)	Hedging Instruments	2020		2019		of Hedged Items	2020		2019
Interest rate contracts	Financing costs, net	$	(1)	$	3	Financing costs, net	$	1	$	(3)

As of June 30, 2020, AOCI included $36 million of net losses (net of income taxes of $13 million) on settled commodities-related derivatives instruments, T-Locks, and foreign currency hedges designated as cash flow hedges that are expected to be reclassified into earnings during the next 12 months.

14

Fair Value Measurements: Presented below are the fair values of the Company’s financial instruments and derivatives for the periods presented:

	As of June 30, 2020								As of December 31, 2019
(in millions)	Total		Level 1 (a)		Level 2 (b)		Level 3 (c)		Total		Level 1 (a)		Level 2 (b)		Level 3 (c)
Available for sale securities	$	10	$	10	$	—	$	—	$	13	$	13	$	—	$	—
Derivative assets		12		2		10		—		24		7		17		—
Derivative liabilities		53		21		32		—		36		5		31		—
Long-term debt		2,215		—		2,215		—		1,751		—		1,751		—

(a) Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities.

(b) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 2 inputs are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data.  

(c) Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

The carrying values of cash equivalents, short-term investments, accounts receivable, accounts payable and short-term borrowings approximate fair values. Commodity futures, options, and swap contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of the Company’s Long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities. As of June 30, 2020, the carrying value and fair value of the Company’s Long-term debt was $2.1 billion and $2.2 billion, respectively.

7. Debt

As of June 30, 2020 and December 31, 2019, the Company’s total debt consisted of the following:

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
2.900% senior notes due June 1, 2030	$	594	$	—
3.200% senior notes due October 1, 2026		497		497
3.900% senior notes due June 1, 2050		390		—
6.625% senior notes due April 15, 2037		253		253
4.625% senior notes due November 1, 2020		—		400
5.62% senior notes due March 25, 2020		—		200
Term loan credit agreement due April 12, 2021		405		405
Revolving credit facility		—		10
Other long-term borrowings		1		—
Fair value adjustment related to hedged fixed rate debt instruments		—		1
Long-term debt		2,140		1,766
4.625% senior notes due November 1, 2020		400		—
Other short-term borrowings		70		82
Short-term debt		470		82
Total debt	$	2,610	$	1,848

During the three months ended March 31, 2020, the Company used proceeds from the revolving credit facility (“Revolving Credit Facility”) to refinance $200 million of its 5.62% senior notes due March 25, 2020.

During the three months ended June 30, 2020, the Company sold its (i) 2.900% senior notes due 2030 in the principal amount of $600 million (the “2030 Notes”) and (ii) 3.900% senior notes due 2050 in the principal amount of $400 million (the “2050 Notes” and, together with the “2030 Notes,” the “Notes”).  The Company recorded the aggregate discount of approximately $7 million at which the Notes were issued and capitalized debt issuance costs of approximately $9 million associated with the Notes.

15

During the three months ended June 30, 2020, the Company applied the net proceeds from the sale of the Notes to pay in full the outstanding balance of $394 million under the Revolving Credit Facility and to set aside funds to repay its 4.625% senior notes due November 1, 2020 (the “2020 Notes”).  On June 8, 2020, the Company issued a notice for the redemption in full of all $400 million principal amount of the 2020 Notes.  The 2020 Notes were redeemed on July 9, 2020 for a total redemption price of $409 million, including accrued interest and a “make-whole” premium as set forth in the indenture.

The Company’s long-term debt as of June 30, 2020, includes the term loan credit agreement due April 12, 2021, as the Company has the ability and intent to refinance it on a long-term basis using our Revolving Credit Facility or other means prior to the maturity date.

8. Leases

The Company determines if an arrangement is a lease at inception of the agreement. Operating leases are included in operating lease assets, and current and non-current operating lease liabilities in the Company’s Condensed Consolidated Balance Sheets. Lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease asset value includes in its calculation any prepaid lease payments made and any lease incentives received from the arrangement as a reduction of the asset.  The Company’s lease terms may include options to extend or terminate the lease, and the impact of these options is included in the lease liability and lease asset calculations when the exercise of the option is at the Company’s sole discretion and it is reasonably certain that the Company will exercise that option. The Company will not separate lease and non-lease components for its leases when it is impracticable to separate the two, such as for leases with variable payment arrangements. Leases with an initial term of 12 months or less are not recorded on the balance sheet.

The Company has operating leases for certain rail cars, office space, warehouses, and machinery and equipment.  The commencement date used for the calculation of the lease obligations recorded is the latter of the commencement date of the new standard (January 1, 2019) or the lease start date.  Certain of the leases have options to extend the life of the lease, which are included in the liability calculation when the option is at the sole discretion of the Company and it is reasonably certain that the Company will exercise the option.  The Company has certain leases that have variable payments based solely on output or usage of the leased asset.  These variable operating lease assets are excluded from the Company’s balance sheet presentation and expensed as incurred.  The Company currently has no finance leases.

Lease expense for lease payments is recognized on a straight-line basis over the lease term. The components of lease expense were as follows:

	Three Months Ended				Six Months Ended
Lease Cost	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Operating lease cost	$	13	$	14	$	26	$	27
Variable operating lease cost		7		6		15		12
Short term lease cost		1		1		2		1
Lease cost	$	21	$	21	$	43	$	40

16

The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities and the related operating lease assets as presented on the Condensed Consolidated Balance Sheet as of June 30, 2020.

Operating Leases		As of
(in millions)		June 30, 2020
2020 (Excluding the six months ended June 30, 2020)	$	26
2021		44
2022		35
2023		26
2024		18
Thereafter		34
Total future lease payments		183
Less imputed interest		27
Present value of future lease payments		156
Less current lease liabilities		41
Non-current operating lease liabilities	$	115
Operating lease assets	$	149

Additional information related to the Company’s operating leases is listed below.

	Three Months Ended				Six Months Ended
Other Information	June 30,				June 30,
($ in millions)	2020		2019		2020			2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	13	$	14	$	26		$	29
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases	$	13	$	6	$	21		$	167
					As of			As of
					June 30, 2020			December 31, 2019
Weighted average remaining lease term:
Operating leases						5.2 years			5.5 years
Weighted average discount rate:
Operating leases						5.5	%		5.7	%

9. Taxes

The Company’s effective tax rate for the three months ended June 30, 2020 decreased to 28.7 percent from 29.6 percent during the three months ended June 30, 2019.  The decrease in the effective income tax rate was primarily driven by a reduction in the Company’s U.S. global intangible low-taxed income (“GILTI”), an adjustment for inflation in Mexico and utilization of previously unbenefited net operating losses compared to an increase in valuation allowance in the 2019 period.  The decrease was partially offset by an increase in Argentine hyperinflation adjustments.

The effective tax rate for the six months ended June 30, 2020 was 37.0 percent compared to 28.2 percent during the six months ended June 30, 2019. The increase in the effective tax rate was driven by a 22 percent decrease in the valuation of the Mexican peso against the U.S. dollar during the six months ended June 30, 2020.  Because the Company uses the U.S. dollar as the functional currency for its subsidiaries in Mexico, its effective tax rate is strongly influenced by the remeasurement of the Mexican peso financial statements into U.S. dollars.  In addition, the decrease in the valuation of the Mexican peso against the U.S. dollar produced taxable translation gains on net-U.S.-dollar-monetary assets held in Mexico for which there was no corresponding gain in pre-tax income.  Consequently, the Company recorded a discrete tax expense of $22 million in the six months ended June 30, 2020, as compared to a $1 million discrete tax benefit in the six months ended June 30, 2019.

17

10. Net Periodic Pension and Postretirement Benefit Costs

The following table sets forth the components of net periodic benefit cost of the U.S. and non-U.S. defined benefit pension plans for the periods presented:

	Three Months Ended June 30,								Six Months Ended June 30,
	U.S. Plans				Non-U.S. Plans				U.S. Plans				Non-U.S. Plans
(in millions)	2020		2019		2020		2019		2020		2019		2020		2019
Service cost	$	1	$	1	$	1	$	1	$	2	$	2	$	2	$	2
Interest cost		3		3		3		2		6		7		6		5
Expected return on plan assets		(6)		(4)		(2)		(2)		(11)		(9)		(4)		(4)
Amortization of actuarial loss		—		—		1		1		—		—		1		1
Net periodic benefit cost (a)	$	(2)	$	—	$	3	$	2	$	(3)	$	—	$	5	$	4

The Company currently anticipates that it will make approximately $4 million in cash contributions to its pension plans in 2020, consisting of $3 million to its non-U.S. pension plans and $1 million to its U.S. pension plans. For the six months ended June 30, 2020, cash contributions of approximately $1 million were made to the non-U.S. plans and an insignificant amount to the U.S. plans.

The following table sets forth the components of net postretirement benefit cost for the periods presented:

	Three Months Ended June 30,				Six Months Ended June 30,
(in millions)	2020		2019		2020		2019
Service cost	$	—	$	—	$	—	$	—
Interest cost		1		—		2		1
Amortization of prior service credit		—		—		(1)		(1)
Net periodic benefit cost (a)	$	1	$	—	$	1	$	—

(a) The service cost component of net periodic benefit cost is presented within either cost of sales or operating expenses on the Condensed Consolidated Statements of Income. The interest cost, expected return on plan assets, amortization of prior service credit, and amortization of actuarial loss components of net periodic benefit cost are presented as other, non-operating income on the Condensed Consolidated Statements of Income.

11. Inventories

Inventories are summarized as follows:

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
Finished and in process	$	552	$	565
Raw materials		246		237
Manufacturing supplies and other		61		59
Total inventories	$	859	$	861

12. Equity

Treasury stock: On October 22, 2018, the Board of Directors authorized a new stock repurchase program permitting the Company to purchase up to 8 million of its outstanding common shares from November 5, 2018 through December 31, 2023.  The parameters of the Company’s stock repurchase program are not established solely with reference to the dilutive impact of shares issued under the Company’s stock incentive plan. However, the Company expects that, over time, share repurchases will offset the dilutive impact of shares issued under the stock incentive plan.

On November 5, 2018, the Company entered into a Variable Timing Accelerated Share Repurchase (“ASR”) program with JPMorgan (“JPM”).  Under the ASR program, the Company paid $455 million on November 5, 2018, and acquired 4 million shares of its common stock having an approximate value of $423 million on that date.  On February 5, 2019, the Company and JPM settled the difference between the initial price and average daily volume weighted average price (“VWAP”) less the agreed upon discount during the term of the ASR agreement.  The final VWAP was $98.04 per share, which was less than originally paid.  The Company settled the difference in cash, resulting in JPM returning $63

18

million of the upfront payment to the Company on February 6, 2019, and lowering the total cost of repurchasing the 4 million shares of common stock to $392 million.  The Company adjusted Additional paid-in capital and Treasury stock by $32 million and $31 million, respectively, during the six months ended June 30, 2019 for this inflow of cash. In the three and six months ended June 30, 2020, the Company did not repurchase shares of common stock.

Shared-based payments: The following table summarizes the components of the Company’s share-based compensation expense:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Stock options:
Pre-tax compensation expense	$	1	$	1	$	2	$	2
Income tax benefit		—		—		—		—
Stock option expense, net of income taxes		1		1		2		2
Restricted stock units ("RSUs"):
Pre-tax compensation expense		3		3		6		5
Income tax benefit		—		(1)		(1)		(1)
RSUs, net of income taxes		3		2		5		4
Performance shares and other share-based awards:
Pre-tax compensation expense		2		2		4		3
Income tax benefit		—		—		—		—
Performance shares and other share-based compensation expense, net of income taxes		2		2		4		3
Total share-based compensation:
Pre-tax compensation expense		6		6		12		10
Income tax benefit		—		(1)		(1)		(1)
Total share-based compensation expense, net of income taxes	$	6	$	5	$	11	$	9

Stock Options: Under the Company’s stock incentive plan, stock options are granted at exercise prices that equal the market value of the underlying common stock on the date of grant. The options have a 10-year term and are exercisable upon vesting, which occurs over a three-year period at the anniversary dates of the date of grant. Compensation expense is generally recognized on a straight-line basis for all awards over the employee’s vesting period or over a one-year required service period for certain retirement-eligible executive level employees. The Company estimates a forfeiture rate at the time of grant and updates the estimate throughout the vesting period of the stock options within the amount of compensation costs recognized in each period.

The Company granted non-qualified options to purchase 336 thousand shares and 247 thousand shares for the six months ended June 30, 2020 and 2019, respectively. The fair value of each option grant was estimated using the Black-Scholes option-pricing model with the following assumptions at the date of grant:

	Six Months Ended June 30,
	2020		2019
Expected life (in years)	5.5		5.5
Risk-free interest rate	1.4	%	2.5	%
Expected volatility	19.8	%	19.7	%
Expected dividend yield	2.9	%	2.7	%

The expected life of options represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting schedules and the Company’s historical exercise patterns. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date for the period corresponding to the expected life of the options. Expected volatility is based on historical volatilities of the Company’s common stock. Dividend yield is based on current dividend payments at the date of grant.

19

Stock option activity for the six months ended June 30, 2020 was as follows:

	Number of Options (in thousands)	Weighted Average Exercise Price per Share		Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019	2,055	$	84.36	5.30	$	34
Granted	336		88.35
Exercised	(91)		45.01
Cancelled	(7)		81.09
Outstanding as of June 30, 2020	2,293	$	86.53	5.64	$	15
Exercisable as of June 30, 2020	1,742	$	84.05	4.58	$	15

For the six months ended June 30, 2020, cash received from the exercise of stock options was $5 million. As of June 30, 2020, the unrecognized compensation cost related to non-vested stock options totaled $4 million, which is expected to be amortized over the weighted-average period of approximately 1.7 years.

Additional information pertaining to stock option activity is as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(dollars in millions, except per share)	2020		2019		2020		2019
Weighted average grant date fair value of stock options granted (per share)	$	—	$	—	$	11.48	$	14.02
Total intrinsic value of stock options exercised	$	—	$	2	$	4	$	6

Restricted Stock Units: The Company has granted RSUs to certain key employees. The RSUs are subject to cliff vesting, generally after three years provided the employee remains in the service of the Company. Compensation expense is generally recognized on a straight-line basis for all awards over the employee’s vesting period or over a one-year required service period for certain retirement-eligible executive level employees. The Company estimates a forfeiture rate at the time of grant and updates the estimate throughout the vesting period of the RSUs within the amount of compensation costs recognized in each period. The fair value of the RSUs is determined based upon the number of shares granted and the market price of the Company’s common stock on the date of the grant.

The following table summarizes RSU activity for the six months ended June 30, 2020:

(RSUs in thousands)	Number of Restricted Shares	Weighted Average Fair Value per Share
Non-vested as of December 31, 2019	339	$	108.02
Granted	171		88.29
Vested	(92)		117.25
Cancelled	(12)		104.34
Non-vested as of June 30, 2020	406	$	97.75

As of June 30, 2020, the total remaining unrecognized compensation cost related to RSUs was $21 million, which will be amortized over a weighted average period of approximately 2.0 years.

Performance Shares: The Company has a long-term incentive plan for senior management in the form of performance shares. Historically these performance shares vested based solely on the Company’s total shareholder return as compared to the total shareholder return of its peer group over the three-year vesting period. Beginning with the 2019 performance share grants, the vesting of the performance shares are based on two performance metrics. Fifty percent of the performance shares awarded will vest based on the Company’s total shareholder return as compared to the total shareholder return of its peer group, and the remaining fifty percent will vest based on the calculation of the Company’s three-year average Return on Invested Capital (“ROIC”) against an established ROIC target.

For the 2020 performance shares awarded based on the Company’s total shareholder return, the number of shares that ultimately vest can range from zero to 200 percent of the awarded grant depending on the Company’s total shareholder return as compared to the total shareholder return of its peer group. The share award vesting will be calculated at the end

20

of the three-year period and is subject to approval by management and the Compensation Committee of the Board of Directors. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. The total compensation expense for these awards is amortized over a three-year graded vesting schedule.

For the 2020 performance shares awarded based on ROIC, the number of shares that ultimately vest can range from zero to 200 percent of the awarded grant depending on the Company’s ROIC performance against the target. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee. Compensation expense is based on the market price of the Company’s common stock on the date of the grant and the final number of shares that ultimately vest.  The Company will estimate the potential share vesting at least annually to adjust the compensation expense for these awards over the vesting period to reflect the Company’s estimated ROIC performance versus the target. The total compensation expense for these awards is amortized over a three-year graded vesting schedule.

For the six months ended June 30, 2020, the Company awarded 81 thousand performance shares at a weighted average fair value of $94.48 per share.

As of June 30, 2020, the unrecognized compensation cost related to these awards was $8 million, which will be amortized over the remaining requisite service period of 2.2 years.

The 2017 performance share awards vested during the six months ended June 30, 2020, achieving a zero percent payout of the granted performance shares.  Additionally, there were zero performance share cancellations during the six months ended June 30, 2020.

Accumulated Other Comprehensive Loss: The following is a summary of net changes in Accumulated other comprehensive loss by component and net of tax for the six months ended June 30, 2020 and 2019:

(in millions)	Cumulative Translation Adjustment		Deferred (Loss) Gain on Hedging Activities		Pension and Postretirement Adjustment		Accumulated Other Comprehensive Loss
Balance, December 31, 2019	$	(1,089)	$	(9)	$	(60)	$	(1,158)
Other comprehensive loss before reclassification adjustments		(118)		(66)		—		(184)
Amount reclassified from accumulated OCI		—		25		—		25
Tax benefit		—		10		—		10
Net other comprehensive loss		(118)		(31)		—		(149)
Balance, June 30, 2020	$	(1,207)	$	(40)	$	(60)	$	(1,307)

(in millions)	Cumulative Translation Adjustment		Deferred (Loss) Gain on Hedging Activities		Pension and Postretirement Adjustment		Accumulated Other Comprehensive Loss
Balance, December 31, 2018	$	(1,080)	$	(5)	$	(69)	$	(1,154)
Other comprehensive income (loss) before reclassification adjustments		(3)		1		(1)		(3)
Amount reclassified from accumulated OCI		—		6		—		6
Tax provision		—		(1)		—		(1)
Net other comprehensive income (loss)		(3)		6		(1)		2
Balance, June 30, 2019	$	(1,083)	$	1	$	(70)	$	(1,152)

21

Supplemental Information: The following Condensed Consolidated Statements of Equity and Redeemable Equity provide the dividends per share for common stock for the periods presented:

	Total Equity														Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2019	$	—	$	1	$	1,137	$	(1,040)	$	(1,158)	$	3,780	$	21	$	31
Net income attributable to Ingredion												75
Net income attributable to non-controlling interests														3
Dividends declared, common stock ($0.63/share)												(42)
Share-based compensation, net of issuance						5		12								(8)
Other comprehensive loss										(164)				(3)
Balance, March 31, 2020	$	—	$	1	$	1,142	$	(1,028)	$	(1,322)	$	3,813	$	21	$	23
Net income attributable to Ingredion												66
Net income attributable to non-controlling interests														1
Dividends declared, common stock ($0.63/share)												(43)
Dividends declared, non-controlling interests														(3)
Share-based compensation, net of issuance						1		1								4
Other comprehensive income										15				1
Balance, June 30, 2020	$	—	$	1	$	1,143	$	(1,027)	$	(1,307)	$	3,836	$	20	$	27

	Total Equity														Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2018	$	—	$	1	$	1,096	$	(1,091)	$	(1,154)	$	3,536	$	20	$	37
Net income attributable to Ingredion												100
Net income attributable to non-controlling interests														2
Dividends declared, common stock ($0.625/share)												(42)
Repurchases of common stock						32		31
Share-based compensation, net of issuance						9		10								(16)
Other comprehensive loss										(6)
Balance, March 31, 2019	$	—	$	1	$	1,137	$	(1,050)	$	(1,160)	$	3,594	$	22	$	21
Net income attributable to Ingredion												105
Net income attributable to non-controlling interests														2
Dividends declared, common stock ($0.625/share)												(43)
Dividends declared, non-controlling interests														(4)
Share-based compensation, net of issuance						1		3								4
Other comprehensive income (loss)										8				(4)
Balance, June 30, 2019	$	—	$	1	$	1,138	$	(1,047)	$	(1,152)	$	3,656	$	16	$	25

22

Supplemental Information: The following table provides the computation of basic and diluted earnings per common share ("EPS") for the periods presented:

	Three Months Ended June 30, 2020					Three Months Ended June 30, 2019
(in millions, except per share amounts)	Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount		Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount
Basic EPS	$	66	67.2	$	0.98	$	105	66.9	$	1.57
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards			0.4					0.5
Diluted EPS	$	66	67.6	$	0.98	$	105	67.4	$	1.56

	Six Months Ended June 30, 2020					Six Months Ended June 30, 2019
(in millions, except per share amounts)	Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount		Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount
Basic EPS	$	141	67.2	$	2.10	$	205	66.9	$	3.06
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards			0.5					0.5
Diluted EPS	$	141	67.7	$	2.08	$	205	67.4	$	3.04

For the three and six months ended June 30, 2020 approximately 1.6 million and 1.3 million share-based awards of common stock, respectively, were excluded from the calculation of diluted EPS as the impact of their inclusion would have been anti-dilutive. For the three and six months ended June 30, 2019, approximately 1.0 million and 1.0 million share-based awards of common stock, respectively, were excluded from the calculation of diluted EPS as the impact of their inclusion would have been anti-dilutive.

13. Segment Information

The Company is principally engaged in the production and sale of starches and sweeteners for a wide range of industries, and is managed geographically on a regional basis. The Company’s operations are classified into four reportable business segments: North America, South America, Asia-Pacific, and EMEA.  Its North America segment includes businesses in the U.S., Mexico, and Canada. The Company’s South America segment includes businesses in Brazil, Colombia, Ecuador, and the Southern Cone of South America, which includes Argentina, Peru, Chile, and Uruguay. Its Asia-Pacific segment includes businesses in South Korea, Thailand, China, Australia, Japan, Indonesia, Singapore, the Philippines, India, Malaysia, New Zealand, and Vietnam. The Company’s EMEA segment includes businesses in Pakistan, Germany, the United Kingdom, South Africa, and Kenya. The Company does not aggregate its operating segments when determining its reportable segments. Net sales by product are not presented because to do so would be impracticable.

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Net sales to unaffiliated customers:
North America	$	848	$	977	$	1,811	$	1,928
South America		182		226		419		454
Asia-Pacific		187		203		376		406
EMEA		132		144		286		298
Total net sales	$	1,349	$	1,550	$	2,892	$	3,086

23

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Operating income:
North America	$	101	$	139	$	226	$	264
South America		13		16		39		34
Asia-Pacific		22		23		42		43
EMEA		21		23		48		47
Corporate		(30)		(23)		(61)		(44)
Subtotal		127		178		294		344
Restructuring/impairment charges		(11)		(9)		(25)		(13)
Acquisition/integration costs		(3)		(1)		(3)		(2)
Total operating income	$	113	$	168	$	266	$	329

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
Assets:
North America (a)	$	4,611	$	3,924
South America		647		774
Asia-Pacific		838		843
EMEA		515		499
Total assets	$	6,611	$	6,040

(a) For purposes of presentation, North America includes Corporate assets.

14. Subsequent Event

On July 1, 2020, the Company completed its acquisition of PureCircle Limited (“PureCircle”) through its wholly owned subsidiary Ingredion SRSS Holdings Limited (“Ingredion SRSS”), an unlisted United Kingdom private limited company. To complete the closing, the Company made a total cash payment of $222 million, which it funded from cash on hand.  Upon the closing, PureCircle is wholly owned by Ingredion SRSS, which in turn is 75%-owned by Ingredion and 25%-owned by former PureCircle shareholders. PureCircle will be consolidated by Ingredion for financial reporting purposes.

24

ITEM 2

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless the context indicates otherwise, references to “we,” “us,” “our,” the “Company” and “Ingredion” mean Ingredion Incorporated and its consolidated subsidiaries.

Overview

We are a major supplier of high-quality food and industrial ingredient solutions to customers around the world. As of June 30, 2020, we have 43 manufacturing plants located in North America, South America, Asia-Pacific and Europe, the Middle East and Africa (“EMEA”), and we manage and operate our businesses at a regional level. We believe this approach provides us with a unique understanding of the cultures and product requirements in each of the geographic markets in which we operate, bringing added value to our customers. Our ingredients are used by customers in the food, beverage, brewing, and animal nutrition industries, among others.

Our new strategic growth roadmap is based on five growth platforms and is designed to deliver shareholder value by accelerating customer co-creation and enabling consumer-preferred innovation. Our first platform is starch-based texturizers, the second platform is clean and simple ingredients, the third platform is plant-based proteins, the fourth platform is sugar reduction and specialty sweeteners, and finally, our fifth platform is value-added food systems.  

Our operations in recent periods have been adversely affected by impacts of COVID-19. On March 11, 2020, the World Health Organization declared COVID-19 a pandemic, and on March 13, 2020 the United States declared a national emergency with respect to COVID-19. Our global operations expose us to risks associated with public health crises, including pandemics such as COVID-19.  Foreign governmental organizations and governmental organizations at the national, state and local levels in the United States have taken various actions to combat the spread of COVID-19, including imposing stay-at-home orders and closing “non-essential” businesses and their operations.  As a manufacturer of food ingredients, our operations are considered “essential” under most current COVID-19 government regulations, and our facilities are operating globally.  During the three months ended June 30, 2020, we experienced volume declines throughout the reporting segments of our business. We did not experience any material supply chain interruptions during the period and were able to continue to operate and ship products from our global network of plants.  We place top priority on our employees’ health and safety and continue to follow the advice and the guidelines of public health authorities for physical distancing and to make available personal protective equipment and sanitization supplies.  

As it is difficult to predict the progression of the pandemic, including government responses and the timing of recovery, there is a range of potential outcomes for our financial performance in future periods. We anticipate continued adverse impacts from COVID-19 on net sales across our reportable segments during the second half of 2020, with recovery in sales generally correlated with the easing of governmental restrictions and increased consumer mobility.  With prevailing pandemic case rates across many countries, we expect away-from-home consumption to continue to be suppressed, reducing volumes for ingredients that are formulated for food and beverages consumed away-from-home.  We anticipate demand for food consumed in home to remain elevated, increasing volumes for ingredients that are part of the recipes for these meals.

For the three months ended June 30, 2020, operating income, net income and diluted earnings per share decreased from the comparable 2019 period. The decreases for the current quarter were attributable primarily to reductions in volumes driven by government mandated shutdowns associated with COVID-19, particularly in the Americas and increased restructuring costs associated with our Cost Smart program.  

For the three and six months ended June 30, 2020, we recorded a total of $11 million and $25 million of pre-tax restructuring charges, respectively, as part of our Cost Smart program.  For the three months ended June 30, 2020, we recorded $6 million of pre-tax restructuring charges for our Cost Smart cost of sales program, including $3 million of asset write-offs and $1 million of other costs in relation to the closure of the Lane Cove, Australia production facility. During the three months ended June 30, 2020, we also recorded $1 million of accelerated depreciation and $1 million of employee-related severance, primarily related to our potato production facilities in North America. For the six months ended June 30, 2020, we recorded $15 million of pre-tax restructuring charges for our Cost Smart cost of sales program, including $6 million of asset write-offs, $2 million of other costs, and $1 million of accelerated depreciation in relation to the closure of the Lane Cove, Australia production facility. We expect to incur $2 million of additional restructuring costs during the

25

remainder of 2020 related to the Lane Cove production facility closure. During the six months ended June 30, 2020, we also recorded $4 million of accelerated depreciation, $1 million of employee-related severance, and $1 million of other costs, primarily related to our potato production facilities in North America.

Additionally, the Company recorded pre-tax restructuring charges of $5 million and $10 million during the three and six months ended June 30, 2020, respectively, for its Cost Smart selling, general and administrative expense (“SG&A”) program. During the three months ended June 30, 2020, we recorded $5 million of pre-tax restructuring charges, consisting primarily of other costs, including professional services, in North America. During the six months ended June 30, 2020, we recorded pre-tax restructuring costs of $10 million primarily in North America, consisting of $8 million of other costs, including professional services, and $2 million of employee-related severance.

Our cash provided by operating activities increased to $294 million for the six months ended June 30, 2020, from $253 million in the prior year, driven by our changes in working capital, partially offset by lower net income.  Our cash provided by financing activities was $683 million during the six months ended June 30, 2020, compared to cash used by financing activities of $75 million in the prior year.  This increase was mainly driven by higher net borrowings during the period, including as a result of our issuance and sale of $1.0 billion of senior notes in the three months ended June 30, 2020.  

Results of Operations

We have significant operations in four reporting segments: North America, South America, Asia-Pacific and EMEA. For most of our foreign subsidiaries, the local foreign currency is the functional currency. Accordingly, revenues and expenses denominated in the functional currencies of these subsidiaries are translated into U.S. dollars at the applicable average exchange rates for the period. Fluctuations in foreign currency exchange rates affect the U.S. dollar amounts of our foreign subsidiaries’ revenues and expenses. The impact of foreign currency translation to the reporting currency, where significant, is provided below.

We acquired Western Polymer LLC (“Western Polymer”) on March 1, 2019. The results of the acquired business is included in our consolidated financial results from the respective acquisition date forward.

For the Three Months Ended June 30, 2020

With Comparatives for the Three Months Ended June 30, 2019

	Three Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales	$	1,349	$	1,550	$	(201)	(13)	%
Cost of sales		1,078		1,221		143	12	%
Gross profit		271		329		(58)	(18)	%
Operating expenses		147		154		7	5	%
Other income, net		—		(2)		(2)	100	%
Restructuring/impairment charges		11		9		(2)	(22)	%
Operating income		113		168		(55)	(33)	%
Financing costs, net		19		16		(3)	(19)	%
Other, non-operating expense/(income), net		—		—		—	—	%
Income before income taxes		94		152		(58)	(38)	%
Provision for income taxes		27		45		18	40	%
Net income		67		107		(40)	(37)	%
Less: Net income attributable to non-controlling interests		1		2		1	50	%
Net income attributable to Ingredion	$	66	$	105	$	(39)	(37)	%

26

Net income attributable to Ingredion. Net income attributable to Ingredion for the three months ended June 30, 2020 decreased by 37 percent to $66 million from $105 million for the three months ended June 30, 2019.  The decrease in net income was primarily due to decreases largely attributable to volume declines in the Americas, driven by COVID-19, which were partly offset by improved price/product mix.  Results for the second quarter of 2020 include after-tax net restructuring costs of $8 million primarily associated with our Cost Smart program. Results for the second quarter of 2019 include after-tax costs of $7 million of net restructuring costs primarily associated with the Cost Smart program.

Net sales. Net sales were down for the three months ended June 30, 2020 as compared to the three months ended June 30, 2019, primarily driven by sales volumes declines in North and South America.

Cost of sales. Cost of sales for the three months ended June 30, 2020 were $1.1 billion compared to $1.2 billion for the months ended June 30, 2019, representing a decrease of $143 million. Our gross profit margin decreased from 21 percent for the three months ended June 30, 2019 to 20 percent for the three months ended June 30, 2020.  The change in gross margin was driven by higher unabsorbed fixed costs during the period and COVID-19 related expenditures, including personal protective equipment and interim appreciation pay to employees in our manufacturing facilities.

Operating expenses. Our operating expenses decreased 5 percent to $147 million for the three months ended June 30, 2020 as compared to $154 million for the three months ended June 30, 2019. The decrease was primarily driven by savings associated with our Cost Smart program and reduced travel costs.  Operating expenses, as a percentage of net sales, was 11 percent for the three months ended June 30, 2020 and 10 percent for the three months ended June 30, 2019.  The increase in this ratio was driven by the reduction in Net sales for the period.

Financing costs, net. Financing costs for the three months ended June 30, 2020 increased to $19 million from $16 million for the three months ended June 30, 2019.  The increase was driven by foreign exchange losses compared to gains in the comparable prior year period.  These losses were partly offset by lower net interest costs on long-term debt.

Provision for income taxes. Our effective tax rate for the three months ended June 30, 2020 was 28.7 percent compared to 29.6 percent for the three months ended June 30, 2019. The decrease in the effective income tax rate was primarily driven by a reduction in our U.S. global intangible low-taxed income (“GILTI”), an adjustment for inflation in Mexico and utilization of previously unbenefited net operating losses compared to an increase in valuation allowance in the 2019 period.  The decrease in the effective tax rate was partially offset by an increase in Argentine hyperinflation adjustments.        

Segment Results

North America

	Three Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	848	$	977	$	(129)	(13)	%
Operating income		101		139		(38)	(27)	%

Net sales. Our decrease in net sales of 13 percent for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019, was driven by a 15 percent reduction in volume which was partly offset by a 2 improvement in price/product mix.  

Operating income. Our operating income decreased by $38 million for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019. The decrease was driven by significantly lower away-from-home consumption in the U.S. and Canada and the shutdown of brewery customers in Mexico.

27

South America

	Three Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	182	$	226	$	(44)	(19)	%
Operating income		13		16		(3)	(19)	%

Net sales. Our net sales decreased 19 percent for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019, primarily due to an 18 percent unfavorable foreign exchange impact and a 11 percent reduction in volume, partly offset by favorable price/product mix of 10 percent.  

Operating income. Our decrease in operating income of $3 million for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019, was largely attributable to unfavorable foreign currency impacts and stay-at-home orders negatively impacting sales volume, partially offset by favorable price/ product mix.

Asia-Pacific

	Three Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	187	$	203	$	(16)	(8)	%
Operating income		22		23		(1)	(4)	%

Net sales. Our net sales decreased 8 percent for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019.  The decrease was primarily driven by unfavorable volume, foreign exchange impacts, and price/product mix of 4 percent, 3 percent, and 1 percent, respectively.

Operating income. Our operating income decreased by $1 million for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019. The decrease was largely attributable to the impact of stay-at-home orders on sales volume, partially offset by improved tapioca margins and lower operating expenses.  

EMEA

	Three Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	132	$	144	$	(12)	(8)	%
Operating income		21		23		(2)	(9)	%

Net sales. Our net sales decreased by 8 percent for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019, primarily driven by unfavorable foreign exchange impacts of 6 percent and decreased volumes of 5 percent, partially offset by a 3 percent favorable price/product mix.

Operating income. Our operating income decreased $2 million for the three months ended June 30, 2020, as compared to the June 30, 2019. The decrease was largely attributable to stay-at-home orders impacting production and sales in Pakistan, partially offset by strong pricing actions and strong EMEA specialty sales volume.  

28

For the Six Months Ended June 30, 2020

With Comparatives for the Six Months Ended June 30, 2019

	Six Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales	$	2,892	$	3,086	$	(194)	(6)	%
Cost of sales		2,298		2,441		143	6	%
Gross profit		594		645		(51)	(8)	%
Operating expenses		301		304		3	1	%
Other income, net		2		(1)		(3)	300	%
Restructuring/impairment charges		25		13		(12)	(92)	%
Operating income		266		329		(63)	(19)	%
Financing costs, net		37		38		1	3	%
Other, non-operating expense/(income), net		(1)		—		1	—	%
Income before income taxes		230		291		(61)	(21)	%
Provision for income taxes		85		82		(3)	(4)	%
Net income		145		209		(64)	(31)	%
Less: Net income attributable to non-controlling interests		4		4		—	—	%
Net income attributable to Ingredion	$	141	$	205	$	(64)	(31)	%

Net income attributable to Ingredion. Net income attributable to Ingredion for the six months ended June 30, 2020 decreased by 31 percent to $141 million from $205 million for the six months ended June 30, 2019.  The decrease in net income was primarily due to decreases in volumes associated with the effects of COVID-19 as well as unfavorable impacts of foreign exchange. Results for the six months ended June 30, 2020 include after-tax net restructuring costs of $19 million primarily associated with our Cost Smart program. Results for the six months ended June 30, 2019 include after-tax costs of $10 million of net restructuring costs primarily associated with our Cost Smart program and $1 million of acquisition/integration costs related to the acquisition and integration of the business acquired from Western Polymer.

Net sales. Net sales decreased by 6 percent for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019, primarily driven by sales volumes declines in North and South America.

Cost of sales. Cost of sales for the six months ended June 30, 2020 decrease by 6 percent as compared to the six months ended June 30, 2019. Our gross profit margin remained flat at 21 percent for the six months ended June 30, 2020 as compared to the six months ended June 30, 2019.  The gross margin was impacted by higher unabsorbed fixed costs during the period and COVID-19 related expenditures.

Operating expenses. Our operating expenses decreased 1 percent to $301 million for the six months ended June 30, 2020 as compared to $304 million for the six months ended June 30, 2019. The decrease was primarily driven by saving from our Cost Smart program in the current period and reduced travel expense.  Operating expenses, as a percentage of net sales, were 10 percent for the six months ended June 30, 2020 and the six months ended June 30, 2019.

Financing costs, net. Financing costs for the six months ended June 30, 2020 decreased to $37 million from $38 million for the six months ended June 30, 2019 primarily due to lower interest costs associated with long-term debt, partially offset by foreign exchange impacts.

Provision for income taxes. Our effective tax rate for the six months ended June 30, 2020 was 37.0 percent compared to 28.2 percent for the six months ended June 30, 2019. The increase in the effective tax rate was driven by the 22 percent decrease in valuation of the Mexican peso against the U.S. dollar during the six months ended June 30, 2020.  Because we use the U.S. dollar as the functional currency for our subsidiaries in Mexico, our effective tax rate is strongly influenced by the remeasurement of the Mexican peso financial statements into U.S. dollars.  In addition, the decrease in

29

valuation of the Mexican peso against the U.S. dollar produced substantial taxable translation gains on net-U.S.-dollar-monetary assets held in Mexico for which there was no corresponding gain in pre-tax income.  Consequently, we recorded a discrete tax expense of $22 million in the six months ended June 30, 2020, as compared to a $1 million discrete tax benefit in the six months ended June 30, 2019.        

Segment Results

North America

	Six Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	1,811	$	1,928	$	(117)	(6)	%
Operating income		226		264		(38)	(14)	%

Net sales. Our decrease in net sales of 6 percent for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019, was driven by decreased volumes of 8 percent partly offset by improved price/product mix.

Operating income. Our operating income decreased by $38 million to $226 million for the six months ended June 30, 2020 compared to $264 million for the six months ended June 30, 2019. The decrease was driven by significantly lower away-from-home consumption in the U.S. and Canada and the shutdown of brewery customers in Mexico.

South America

	Six Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	419	$	454	$	(35)	(8)	%
Operating income		39		34		5	15	%

Net sales. Our net sales decreased 8 percent for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019, primarily due to unfavorable foreign exchange impacts of 15 percent and a reduction in volume of 3 percent partially offset by favorable price/product mix of 10 percent.

Operating income. Our increase in operating income of $5 million for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019, was due to favorable price/product mix, partially offset by unfavorable foreign exchange impacts.  

Asia-Pacific

	Six Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	376	$	406	$	(30)	(7)	%
Operating income		42		43		(1)	(2)	%

Net sales. Our net sales decreased 7 percent for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019, primarily driven by unfavorable foreign exchange impacts, volume, and price/product mix impacts of 3 percent, 3 percent and 1 percent, respectively.

Operating income. Our operating income decreased by $1 million for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019. The decrease was largely attributable to the impact of stay-at-home orders on sales volume, partially offset by improved tapioca margins and lower operating expenses.  

30

EMEA

	Six Months Ended June 30,				Favorable (Unfavorable)		Favorable (Unfavorable)
(in millions)	2020		2019		Variance		Percentage
Net sales to unaffiliated customers	$	286	$	298	$	(12)	(4)	%
Operating income		48		47		1	2	%

Net sales. Our net sales decreased 4 percent for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019. The decrease was driven by unfavorable foreign exchange impacts of 6 percent and reduced volume of 1 percent, partially offset by favorable price/product mix of 3 percent.

Operating income. Our operating income increased $1 million for the six months ended June 30, 2020, as compared to the six months ended June 30, 2019.  The increase was largely attributable to Pakistan pricing action and strong EMEA specialty sales volume, partially offset by the impacts of stay-at-home orders on Pakistan production and sales volume, and negative foreign currency impacts.  

Liquidity and Capital Resources

Cash provided by operating activities for the six months ended June 30, 2020 was $294 million, as compared to $253 million for the six months ended June 30, 2019. The increase in operating cash flow was primarily driven by our changes in working capital, partially offset by lower net income.  Capital expenditures and mechanical stores purchases were $175 million for the six months ended June 30, 2020.

As of June 30, 2020, our total debt consists of the following:

(in millions)
2.900% senior notes due June 1, 2030	$	594
3.200% senior notes due October 1, 2026		497
3.900% senior notes due June 1, 2050		390
6.625% senior notes due April 15, 2037		253
5.62% senior notes due March 25, 2020		—
Term loan credit agreement due April 12, 2021		405
Revolving credit facility		—
Other long-term borrowings		1
Fair value adjustment related to hedged fixed rate debt instruments		—
Long-term debt		2,140
4.625% senior notes due November 1, 2020		400
Other short-term borrowings		70
Short-term debt		470
Total debt	$	2,610

During the three months ended March 31, 2020, we used proceeds from the revolving credit facility (“Revolving Credit Facility”) to refinance $200 million of our 5.62% senior notes due March 25, 2020.

During the three months ended June 30, 2020, we sold our (i) 2.900% senior notes due 2030 in the principal amount of $600 million (the “2030 Notes”) and (ii) 3.900% senior notes due 2050 in the principal amount of $400 million (the “2050 Notes” and, together with the “2030 Notes,” the “Notes”).  We recorded the aggregate discount of approximately $7 million at which the Notes were issued and capitalized debt issuance costs of approximately $9 million associated with the Notes.

During the three months ended June 30, 2020, we applied the net proceeds from the sale of the Notes to pay in full the outstanding balance of $394 million under the Revolving Credit Facility and to set aside funds to repay our 4.625% senior notes due November 1, 2020 (the “2020 Notes”).  On June 8, 2020, we issued a notice for the redemption in full of all $400 million principal amount of the 2020 Notes.  The 2020 Notes were redeemed on July 9, 2020 for a total redemption price of $409 million, including accrued interest and a “make-whole” premium as set forth in the indenture.

31

The Company’s long-term debt as of June 30, 2020, includes the term loan credit agreement due April 12, 2021, as the Company has the ability and intent to refinance it on a long-term basis using our Revolving Credit Facility or other means prior to the maturity date

As of June 30, 2020, in addition to the approximately $1.0 billion of borrowings availability under the Revolving Credit Facility, we have approximately $660 million of unused operating lines of credit in the various foreign countries in which we operate. We are required under our credit facilities not to exceed a maximum leverage ratio and to maintain a minimum interest coverage ratio. As of June 30, 2020, we were in compliance with both of these financial covenants.

The weighted average interest rate on our total indebtedness was approximately 3.4 percent for the six months ended June 30, 2020, compared to 4.5 percent for the six months ended June 30, 2019.

On May 20, 2020, our Board of Directors declared a quarterly cash dividend of $0.63 per share of common stock. This dividend was paid on July 27, 2020, to stockholders of record at the close of business on July 1, 2020.

We have not provided foreign withholding taxes, state income taxes, and federal and state taxes or foreign currency gains/losses on accumulated undistributed earnings of certain foreign subsidiaries because these earnings are considered to be permanently reinvested. It is not practicable to determine the amount of the unrecognized deferred tax liability related to the undistributed earnings. We do not anticipate the need to repatriate funds to the U.S. to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service requirements. Approximately $311 million of the total $1,047 million of cash and cash equivalents and short-term investments at June 30, 2020 was held by our operations outside of the U.S.

We expect that available cash balances and borrowings expected to be available under the Revolving Credit Facility, together with cash generated from operations and our access to debt markets, will be sufficient to meet our operating and other cash needs for at least the next twelve months.

Hedging and Financial Risk

Hedging: We are exposed to market risk stemming from changes in commodity prices (primarily corn and natural gas), foreign-currency exchange rates, and interest rates. In the normal course of business, we actively manage our exposure to these market risks by entering into various hedging transactions, authorized under established policies that place controls on these activities. These transactions utilize exchange-traded derivatives or over-the-counter derivatives with investment grade counterparties. Our hedging transactions may include, but are not limited to, a variety of derivative financial instruments such as commodity-related futures, options and swap contracts, forward currency-related contracts and options, interest rate swap agreements, and Treasury lock agreements (“T-Locks”). See Note 6 of the Notes to the Condensed Consolidated Financial Statements for additional information.

Commodity Price Risk: Our principal use of derivative financial instruments is to manage commodity price risk in North America relating to anticipated purchases of corn and natural gas to be used in our manufacturing process. We periodically enter into futures, options and swap contracts for a portion of our anticipated corn and natural gas usage, generally over the following 12 to 24 months, in order to hedge price risk associated with fluctuations in market prices. Unrealized gains and losses associated with marking our commodities-based cash flow hedge derivative instruments to market are recorded as a component of other comprehensive income (“OCI”). As of June 30, 2020, our Accumulated other comprehensive loss account (“AOCI”) included $36 million of net losses (net of income tax benefit of $13 million) related to these derivative instruments. It is anticipated that $36 million of net losses (net of income tax benefit of $13 million) will be reclassified into earnings during the next 12 months. We expect the net losses to be offset by lower underlying commodities costs.

32

Foreign-Currency Exchange Risk: Due to our global operations, including operations in many emerging markets, we are exposed to fluctuations in foreign-currency exchange rates. As a result, we have exposure to translational foreign-exchange risk when our foreign operations’ results are translated to U.S. dollars and to transactional foreign-exchange risk when transactions not denominated in the functional currency of the operating unit are revalued into U.S. dollars. We primarily use derivative financial instruments such as foreign-currency forward contracts, swaps and options to manage our foreign currency transactional exchange risk. We enter into foreign-currency derivative instruments that are designated as both cash flow hedging instruments as well as instruments not designated as hedging instruments as defined by Accounting Standards Codification 815, Derivatives and Hedging. As of June 30, 2020, we had foreign currency derivatives not designated as hedging instruments hedging certain asset and liability positions with aggregate notional amounts of $590 million and $478 million, respectively.

As of June 30, 2020, we had foreign currency derivatives designated as cash flow hedging instruments hedging certain asset and liability positions with aggregate notional amounts of $325 million and $460 million, respectively. The amount included in AOCI relating to these hedges at June 30, 2020, was an insignificant amount of net losses (net of an insignificant amount of taxes). It is anticipated that an insignificant amount of net losses (net of an insignificant amount of taxes) will be reclassified into earnings during the next 12 months.

Interest Rate Risk: We occasionally use interest rate swaps and T-Locks to hedge our exposure to interest rate changes, to reduce the volatility of our financing costs, or to achieve a desired proportion of fixed versus floating rate debt, based on current and projected market conditions. We did not have outstanding T-Locks as of June 30, 2020.

As of June 30, 2020, AOCI included $4 million of net losses (net of an income tax benefit of $1 million) related to previously settled T-Locks. Once T-Locks are settled, deferred losses are amortized to financing costs over the terms of the senior notes with which they are associated. It is anticipated that an insignificant amount of these net losses (net of an insignificant amount of taxes) will be reclassified into earnings during the next 12 months.

As of June 30, 2020, we did not have any interest rate swap agreements. As of December 31, 2019 we had an interest rate swap that effectively converted the interest rates on $200 million of our $400 million of 4.625% senior notes due November 1, 2020, to variable rates. This swap agreement called for us to receive interest at the fixed coupon rate of the notes and to pay interest at a variable rate based on the six-month U.S. dollar LIBOR plus a spread. As of December 31, 2019, we designated this interest rate swap agreement as a hedge of the changes in fair value of the underlying debt obligation attributable to changes in interest rates and accounted for it as a fair value hedge. The fair value of the interest rate swap agreement as of December 31, 2019 was a $4 million gain, and is reflected in the Condensed Consolidated Balance Sheets within Other assets, with an offsetting amount recorded in Long-term debt to adjust the carrying amount of the hedged debt obligations.

Critical Accounting Policies and Estimates

Our critical accounting policies and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2019. See Note 2 of the Notes to the Condensed Consolidated Financial Statements for additional information regarding our significant accounting policies. There have been no other changes to our critical accounting policies and estimates during the three and six months ended June 30, 2020.

33

FORWARD-LOOKING STATEMENTS

This Form 10-Q contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends these forward-looking statements to be covered by the safe harbor provisions for such statements.

Forward-looking statements include, among other things, any statements regarding the Company’s future financial condition, earnings, revenues, tax rates, capital expenditures, cash flows, expenses or other financial items, any statements concerning the Company’s prospects or future operations, including management’s plans or strategies and objectives therefor, and any assumptions, expectations or beliefs underlying the foregoing.

These statements can sometimes be identified by the use of forward-looking words such as “may,” “will,” “should,” “anticipate,” “assume,” “believe,” “plan,” “project,” “estimate,” “expect,” “intend,” “continue,” “pro forma,” “forecast,” “outlook,” “propels,” “opportunities,” “potential,” “provisional,” or other similar expressions or the negative thereof. All statements other than statements of historical facts in this report or referred to in this report are “forward-looking statements.”

These statements are based on current circumstances or expectations, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and are beyond our control. Although we believe our expectations reflected in these forward-looking statements are based on reasonable assumptions, investors are cautioned that no assurance can be given that our expectations will prove correct.

Actual results and developments may differ materially from the expectations expressed in or implied by these statements as a result of the following risks and uncertainties, among others: changing consumption preferences and perceptions, including those relating to high fructose corn syrup; the effects of global economic conditions and the general political, economic, business, market conditions that affect customers and consumers in the various geographic regions and countries in which we buy our raw materials or manufacture or sell our products, including, particularly, economic, currency and political conditions in South America and economic and political conditions in Europe, and the impact these factors may have on our sales volumes, the pricing of our products, our access to credit markets and our ability to collect our receivables from customers; adverse changes in investment returns earned on our pension assets; future financial performance of major industries which we serve and from which we derive a significant portion of our sales, including the food, beverage, animal nutrition, and brewing industries; the uncertainty of acceptance of products developed through genetic modification and biotechnology; our ability to develop or acquire new products and services at rates or of qualities sufficient to meet expectations; changes in U.S. and foreign government policy, laws or regulations and costs of legal compliance; increased competitive and/or customer pressure in the corn-refining industry and related industries, including with respect to the markets and prices for our primary products and our co-products, particularly corn oil; the availability of raw materials, including potato starch, tapioca, gum Arabic and the specific varieties of corn upon which some of our products are based, and our ability to pass on potential increases in the cost of corn or other raw materials to customers; raw material and energy costs and availability; our ability to contain costs, achieve budgets and realize expected synergies, including with respect to our ability to complete planned maintenance and investment projects on time and on budget, and to achieve expected savings under our Cost Smart program as well as with respect to freight and shipping costs; the impact of financial and capital markets on our borrowing costs, including as a result of foreign currency fluctuations, fluctuations in interest and exchange rates and market volatility and the associated risks of hedging against such fluctuations; the potential effects of climate change; our ability to successfully identify and complete acquisitions or strategic alliances on favorable terms as well as our ability to successfully integrate acquired businesses or implement and maintain strategic alliances and achieve anticipated synergies with respect to all of the foregoing; operating difficulties at our manufacturing plants or with respect to boiler reliability; risks related to product safety and quality and compliance with environmental, health and safety, and food safety laws and regulations; economic, political and other risks inherent in operating in foreign countries with foreign currencies and shipping products between countries, including with respect to tariffs, quotas and duties; interruptions, security breaches or failures that might affect our information technology systems, processes and sites; our ability to maintain satisfactory labor relations; the impact that weather, natural disasters, war or similar acts of hostility, acts and threats of terrorism, the outbreak or continuation of pandemics such as COVID 19 and other significant events could have on our business; the potential recognition of impairment charges on goodwill or long lived assets; changes in our tax rates or exposure to additional income tax liabilities; and our ability to raise funds at reasonable rates to grow and expand our operations.

34

Our forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see “Risk Factors” and other information included in our Annual Report on Form 10-K for the year ended December 31,  2019, in our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020, and in our subsequent reports on Forms 10-Q and 8-K.

ITEM 3

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See the discussion set forth in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk at pages 49 to 50 in our Annual Report on Form 10-K for the year ended December 31, 2019, for a discussion as to how we address risks with respect to interest rates, raw material and energy costs and foreign currencies. There have been no material changes in the information that would be provided with respect to those disclosures from December 31, 2019 to June 30, 2020. For additional information, also see “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Hedging and Financial Risk” in this report.

ITEM 4

CONTROLS AND PROCEDURES

Our management, including our Chief Executive Officer and our Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2020. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of June 30, 2020, our disclosure controls and procedures (a) are effective in providing reasonable assurance that all information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, has been recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (b) are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

There have been no changes in our internal control over financial reporting during the three months ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35

PART II OTHER INFORMATION

ITEM 1

LEGAL PROCEEDINGS

We are currently subject to claims and suits arising in the ordinary course of business, including labor matters, certain environmental proceedings, and other commercial claims.  We also routinely receive inquiries from regulators and other government authorities relating to various aspects of our business, including with respect to compliance with laws and regulations relating to the environment, and at any given time, we have matters at various stages of resolution with the applicable governmental authorities. The outcomes of these matters are not within our complete control and may not be known for prolonged periods of time. We do not believe that the results of currently known legal proceedings and inquires will be material to us. There can be no assurance, however, that such claims, suits or investigations or those arising in the future, whether taken individually or in the aggregate, will not have a material adverse effect on our business, financial condition, or future results of operations.

ITEM 1A

RISK FACTORS

During the six months ended June 30, 2020, there have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, as supplemented by the risk factor disclosed in our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020. The risks discussed in those reports are not the only risks that could materially affect our business, financial condition, or future results.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition, or future results of operations.

ITEM 2

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities:

				Maximum Number
				(or Approximate
			Total Number of	Dollar Value) of
	Total	Average	Shares Purchased as	Shares That May Yet
	Number	Price	Part of Publicly	be Purchased Under
	of Shares	Paid	Announced Plans or	the Plans or Programs
(shares in thousands)	Purchased	per Share	Programs	at End of Period
April 1 – April 30, 2020	—	—	—	5,855 shares
May 1 – May 31, 2020	—	—	—	5,855 shares
June 1 – June 30, 2020	—	—	—	5,855 shares
Total	—	—	—

On December 12, 2014, the Board of Directors authorized a stock repurchase program permitting us to purchase up to 5.0 million shares of our outstanding common stock from January 1, 2015, through December 31, 2019. On October 22, 2018, the Board of Directors authorized a new stock repurchase program permitting us to purchase up to an additional 8.0 million shares of our outstanding common stock from November 5, 2018, through December 31, 2023. As of June 30, 2020, we have 5.9 million shares available for repurchase under the stock repurchase programs.

36

ITEM 6

EXHIBITS

a) Exhibits

Exhibits required by Item 601 of Regulation S-K are listed in the Exhibit Index below.

EXHIBIT INDEX

Number	Description of Exhibit
4.1†	Tenth Supplemental Indenture, dated as of May 13, 2020, between Ingredion Incorporated (the “Company”) and The Bank of New York Mellon Trust Company, N.A. (as successor trustee to The Bank of New York), as trustee, including the form of 2.900% Senior Note due 2030 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “Commission”) on May 13, 2020) (Commission File No. 1-13397).
4.2†	Eleventh Supplemental Indenture, dated as of May 13, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor trustee to The Bank of New York), as trustee, including the form of 3.900% Senior Note due 2050 (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the Commission on May 13, 2020) (Commission File No. 1-13397).
31.1†	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2†	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1††	Certification of Chief Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2††	Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
101.INS†	XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH†	Inline XBRL Taxonomy Extension Schema Document.
101.CAL†	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF†	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB†	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE†	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104†	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document, which is contained in Exhibit 101).

_____________________________________

HIDDEN_ROW
†	Filed with this report.
††	Furnished with this report.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		INGREDION INCORPORATED
DATE:	August 5, 2020	By	/s/ James D. Gray
		James D. Gray
		Executive Vice President and Chief Financial Officer
DATE:	August 5, 2020	By	/s/ Stephen K. Latreille
		Stephen K. Latreille
		Vice President and Corporate Controller

38

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, James P. Zallie, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Ingredion Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  August 5, 2020	/s/ James P. Zallie
	James P. Zallie
	President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, James D. Gray, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Ingredion Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

6
Date:  August 5, 2020	/s/ James D. Gray
	James D. Gray
	Executive Vice President and Chief Financial Officer

EX-32.1

EXHIBIT 32.1

Certification Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the
Sarbanes-Oxley Act of 2002

I, James P. Zallie, the Chief Executive Officer of Ingredion Incorporated, certify that to my knowledge (i) the report on Form 10-Q for the quarter ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ingredion Incorporated.

/s/ James P. Zallie

James P. Zallie

Chief Executive Officer

August 5, 2020

A signed original of this written statement required by Section 906 has been provided to Ingredion Incorporated and will be retained by Ingredion Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

Certification Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the
Sarbanes-Oxley Act of 2002

I, James D. Gray, the Chief Financial Officer of Ingredion Incorporated, certify that to my knowledge (i) the report on Form 10-Q for the quarter ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ingredion Incorporated.

/s/ James D. Gray

James D. Gray

Chief Financial Officer

August 5, 2020

A signed original of this written statement required by Section 906 has been provided to Ingredion Incorporated and will be retained by Ingredion Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2020	Jul. 31, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	1-13397
Entity Registrant Name	Ingredion Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-3514823
Entity Address, Address Line One	5 Westbrook Corporate Center
Entity Address, City or Town	Westchester
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60154
City Area Code	708
Local Phone Number	551-2600
Title of 12(b) Security	Common Stock, $.01 par value per share
Trading Symbol	INGR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		66,987,048
Entity Central Index Key	0001046257
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false

XML

Condensed Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Condensed Consolidated Statements of Income
Net sales	$ 1,349	$ 1,550	$ 2,892	$ 3,086
Cost of sales	1,078	1,221	2,298	2,441
Gross profit	271	329	594	645
Operating expenses	147	154	301	304
Other income, net		(2)	2	(1)
Restructuring/impairment charges	11	9	25	13
Operating income	113	168	266	329
Financing costs, net	19	16	37	38
Other, non-operating income, net			(1)
Income before income taxes	94	152	230	291
Provision for income taxes	27	45	85	82
Net income	67	107	145	209
Less: Net income attributable to non-controlling interests	1	2	4	4
Net income attributable to Ingredion	$ 66	$ 105	$ 141	$ 205
Weighted average common shares outstanding:
Basic (in shares)	67.2	66.9	67.2	66.9
Diluted (in shares)	67.6	67.4	67.7	67.4
Earnings per common share of Ingredion:
Basic (in dollars per share)	$ 0.98	$ 1.57	$ 2.10	$ 3.06
Diluted (in dollars per share)	$ 0.98	$ 1.56	$ 2.08	$ 3.04

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Condensed Consolidated Statements of Comprehensive (Loss) Income
Net income	$ 67	$ 107	$ 145	$ 209
Other comprehensive (loss) income:
(Losses) gains on cash flow hedges, net of income tax effect of $4, $3, $16 and $ - , respectively	(16)	10	(50)	1
Losses on cash flow hedges reclassified to earnings, net of income tax effect of $4, $1, $6 and $1, respectively	15	3	19	5
Actuarial losses on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect of $ -		(1)		(1)
Currency translation adjustment	16	(4)	(118)	(3)
Comprehensive income (loss)	82	115	(4)	211
Less: Comprehensive income (loss) attributable to non-controlling interests	2	(2)	2
Comprehensive income (loss) attributable to Ingredion	$ 80	$ 117	$ (6)	$ 211

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Condensed Consolidated Statements of Comprehensive (Loss) Income
(Losses) gains on cash flow hedges, income tax benefit	$ 4	$ (3)	$ 16
Losses on cash-flow hedges reclassified to earnings, income tax benefit (expense)	$ (4)	$ (1)	$ (6)	$ (1)

XML

Condensed Consolidated Balance Sheet - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 1,047	$ 264
Short-term investments	1	4
Accounts receivable, net	861	977
Inventories	859	861
Prepaid expenses	52	54
Total current assets	2,820	2,160
Property, plant and equipment, net of accumulated depreciation of $3,039 and $3,056, respectively	2,231	2,306
Goodwill	791	801
Other intangible assets, net of accumulated amortization of $210 and $197, respectively	421	437
Operating lease assets	149	151
Deferred income tax assets	17	13
Other assets	182	172
Total assets	6,611	6,040
Current liabilities:
Short-term borrowings	470	82
Accounts payable and accrued liabilities	812	885
Total current liabilities	1,282	967
Non-current liabilities	209	220
Long-term debt	2,140	1,766
Non-current operating lease liabilities	115	120
Deferred income tax liabilities	172	195
Share-based payments subject to redemption	27	31
Ingredion stockholders' equity:
Preferred stock - authorized 25,000,000 shares - $0.01 par value, none issued
Common stock - authorized 200,000,000 shares - $0.01 par value, 77,810,875 issued at June 30, 2020 and December 31, 2019, respectively	1	1
Additional paid-in capital	1,143	1,137
Less: Treasury stock (common stock: 10,825,142 and 10,993,388 shares at June 30, 2020 and December 31, 2019, respectively) at cost	(1,027)	(1,040)
Accumulated other comprehensive loss	(1,307)	(1,158)
Retained earnings	3,836	3,780
Total Ingredion stockholders' equity	2,646	2,720
Non-controlling interests	20	21
Total equity	2,666	2,741
Total liabilities and equity	$ 6,611	$ 6,040

XML

Condensed Consolidated Balance Sheet (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Condensed Consolidated Balance Sheet
Property, plant and equipment, Accumulated depreciation	$ 3,039	$ 3,056
Other intangible assets - accumulated amortization (in dollars)	$ 210	$ 197
Preferred stock, authorized (in shares)	25,000,000	25,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, issued (in shares)	0	0
Common stock, authorized (in shares)	200,000,000	200,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, issued (in shares)	77,810,875	77,810,875
Treasury stock (in shares)	10,825,142	10,993,388

XML

Condensed Consolidated Statements of Equity - USD ($) $ in Millions	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings	Non-Controlling Interests	Total
Balance at Dec. 31, 2018	$ 1	$ 1,096	$ (1,091)	$ (1,154)	$ 3,536	$ 20
Increase (Decrease) in Stockholders' Equity
Net income					100	2
Dividends declared					(42)
Repurchases of common stock, net		32	31
Share-based compensation, net of issuance		9	10
Other comprehensive income (loss)				(6)
Balance at Mar. 31, 2019	1	1,137	(1,050)	(1,160)	3,594	22
Balance at Dec. 31, 2018	1	1,096	(1,091)	(1,154)	3,536	20
Increase (Decrease) in Stockholders' Equity
Net income					205	4	$ 209
Dividends declared					(85)	(4)
Repurchases of common stock, net		32	31
Share-based compensation, net of issuance		10	13
Other comprehensive income (loss)				2		(4)
Balance at Jun. 30, 2019	1	1,138	(1,047)	(1,152)	3,656	16
Balance at Mar. 31, 2019	1	1,137	(1,050)	(1,160)	3,594	22
Increase (Decrease) in Stockholders' Equity
Net income					105	2	107
Dividends declared					(43)	(4)
Share-based compensation, net of issuance		1	3
Other comprehensive income (loss)				8		(4)
Balance at Jun. 30, 2019	1	1,138	(1,047)	(1,152)	3,656	16
Balance at Dec. 31, 2019	1	1,137	(1,040)	(1,158)	3,780	21	2,741
Increase (Decrease) in Stockholders' Equity
Net income					75	3
Dividends declared					(42)
Share-based compensation, net of issuance		5	12
Other comprehensive income (loss)				(164)		(3)
Balance at Mar. 31, 2020	1	1,142	(1,028)	(1,322)	3,813	21
Balance at Dec. 31, 2019	1	1,137	(1,040)	(1,158)	3,780	21	2,741
Increase (Decrease) in Stockholders' Equity
Net income					141	4	145
Dividends declared					(85)	(3)
Share-based compensation, net of issuance		6	13
Other comprehensive income (loss)				(149)		(2)
Balance at Jun. 30, 2020	1	1,143	(1,027)	(1,307)	3,836	20	2,666
Balance at Mar. 31, 2020	1	1,142	(1,028)	(1,322)	3,813	21
Increase (Decrease) in Stockholders' Equity
Net income					66	1	67
Dividends declared					(43)	(3)
Share-based compensation, net of issuance		1	1
Other comprehensive income (loss)				15		1
Balance at Jun. 30, 2020	$ 1	$ 1,143	$ (1,027)	$ (1,307)	$ 3,836	$ 20	$ 2,666

XML

Condensed Consolidated Statement of Redeemable Equity $ in Millions	USD ($)
Beginning Balance at Dec. 31, 2018	$ 37
Share-based Payments Subject to Redemption
Share-based compensation, net of issuance	(16)
Ending Balance at Mar. 31, 2019	21
Beginning Balance at Dec. 31, 2018	37
Share-based Payments Subject to Redemption
Share-based compensation, net of issuance	(12)
Ending Balance at Jun. 30, 2019	25
Beginning Balance at Mar. 31, 2019	21
Share-based Payments Subject to Redemption
Share-based compensation, net of issuance	4
Ending Balance at Jun. 30, 2019	25
Beginning Balance at Dec. 31, 2019	31
Share-based Payments Subject to Redemption
Share-based compensation, net of issuance	(8)
Ending Balance at Mar. 31, 2020	23
Beginning Balance at Dec. 31, 2019	31
Share-based Payments Subject to Redemption
Share-based compensation, net of issuance	(4)
Ending Balance at Jun. 30, 2020	27
Beginning Balance at Mar. 31, 2020	23
Share-based Payments Subject to Redemption
Share-based compensation, net of issuance	4
Ending Balance at Jun. 30, 2020	$ 27

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash provided by operating activities
Net income	$ 145	$ 209
Non-cash charges to net income:
Depreciation and amortization	106	103
Mechanical stores expense	26	28
Deferred income taxes	(2)	10
Other	25	33
Changes in working capital:
Accounts receivable and prepaid expenses	64	(65)
Inventories	(31)	(39)
Accounts payable and accrued liabilities	(21)	(32)
Margin accounts	(18)	15
Other		(9)
Cash provided by operating activities	294	253
Cash used for investing activities
Capital expenditures and mechanical stores purchases, net of proceeds on disposals	(175)	(156)
Payments for acquisitions, net of cash acquired of $ - and $4, respectively		(42)
Investment in non-consolidated affiliates	(6)	(10)
Short-term investments	3	3
Cash used for investing activities	(178)	(205)
Cash provided by (used for) financing activities
Proceeds from borrowings	1,486	714
Payments on debt	(709)	(765)
Payments for debt issuance costs	(9)
Repurchases of common stock, net		63
Issuances of common stock for share-based compensation, net of settlements	2
Dividends paid, including to non-controlling interests	(87)	(87)
Cash provided by (used for) financing activities	683	(75)
Effects of foreign exchange rate changes on cash	(16)	(3)
Increase (decrease) in cash and cash equivalents	783	(30)
Cash and cash equivalents, beginning of period	264	327
Cash and cash equivalents, end of period	$ 1,047	$ 297

XML

Condensed Consolidated Statements of Cash Flows (Parenthetical) $ in Millions	6 Months Ended
	Jun. 30, 2019 USD ($)
Condensed Consolidated Statements of Cash Flows
Cash acquired from acquisition	$ 4

XML

Interim Financial Statements

6 Months Ended

Jun. 30, 2020

Interim Financial Statements

Interim Financial Statements

1. Interim Financial Statements

References to the “Company” are to Ingredion Incorporated (“Ingredion”) and its consolidated subsidiaries. These statements should be read in conjunction with the consolidated financial statements and the related notes to those statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

The unaudited Condensed Consolidated Financial Statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and 2019 included herein were prepared by management on the same basis as the Company’s audited Consolidated Financial Statements for the year ended December 31, 2019 and reflect all adjustments (consisting solely of normal recurring items unless otherwise noted) which are, in the opinion of management, necessary for the fair presentation of the Condensed Consolidated Statements of Income, Condensed Consolidated Statements of Comprehensive Income (Loss), Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows. The results for the interim period are not necessarily indicative of the results expected for the full year.

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2020

Summary of Significant Accounting Policies

Summary of Significant Accounting Standards and Policies

2.     Summary of Significant Accounting Standards and Policies

For detailed information about the Company’s significant accounting standards, see Note 2 of the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Except for the matters discussed below, there have been no other material changes to the Company’s significant accounting policies for the three and six months ended June 30, 2020.

Recently Adopted Accounting Standards

ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350)

In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This Update simplifies the subsequent measurement of goodwill as the Update eliminates Step 2 from the goodwill impairment test. Under the Update, an entity will continue to perform its annual, or interim, goodwill impairment test to determine if the fair value of a reporting unit is greater than its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value using the results of its Step 1 assessment, with the loss recognized not to exceed the total amount of goodwill allocated to that reporting unit. This Update is effective for annual periods beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU 2017-04 at the beginning of its 2020 fiscal year and the Update did not have a material impact on the Company’s Condensed Consolidated Financial Statements upon adoption.

ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326)

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. This Update is effective for annual periods beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU 2016-13 at the beginning of its 2020 fiscal year and the Update did not have a material impact on the Company’s Condensed Consolidated Financial Statements upon adoption.

Net Sales Presentation Change

During the three months ended December 31, 2019, the Company changed its presentation of shipping and handling costs.  These expenses were previously included as a reduction to Net sales in the Condensed Consolidated Statements of Income.  The Company is now presenting these expenses within Cost of sales in the Condensed Consolidated Statements of Income.  The change in presentation was applied retrospectively to all periods presented in the Condensed Consolidated Statements of Income.  The change in presentation had no effect on Gross profit, Operating income, Net income, or Earnings per share.  The Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of

Comprehensive Income (Loss), Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows are not affected by this change in presentation.

The effect of the adjustment is as follows:

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Consolidated Statements of Income:
Net sales before shipping and handling costs	$	1,550	$	—	$	3,086	$	—
Less: shipping and handling costs		116		—		232		—
Net sales		1,434		1,550		2,854		3,086
Cost of sales		1,105		1,221		2,209		2,441
Gross profit	$	329	$	329	$	645	$	645

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Net sales to unaffiliated customers:
North America	$	885	$	977	$	1,745	$	1,928
South America		215		226		433		454
Asia-Pacific		195		203		389		406
EMEA		139		144		287		298
Total	$	1,434	$	1,550	$	2,854	$	3,086

XML

Acquisitions

6 Months Ended

Jun. 30, 2020

Acquisitions

Acquisitions

3. Acquisitions

On March 1, 2019, the Company completed its acquisition of Western Polymer LLC (“Western Polymer”), a privately-held, U.S.-based company headquartered in Moses Lake, Washington, that produces native and modified potato starches for industrial and food applications for $42 million, net of cash acquired of $4 million. The acquisition will expand the Company's potato starch manufacturing capacity, enhance processing capabilities, and broaden its higher-value specialty ingredients business and customer base. The results of the acquired operation are included in the Company’s consolidated results from the acquisition date forward within the North America business segment.

During the three months ended March 31, 2020, the Company finalized the purchase price allocation for the Western Polymer acquisition. The finalization of goodwill and intangible assets did not have a significant impact on previously estimated amounts. The acquisition of Western Polymer added $13 million of goodwill and intangible assets and $29 million of net tangible assets as of the acquisition date.

Goodwill represents the amount by which the purchase price exceeds the estimated fair value of the net assets acquired. The goodwill results from synergies and other operational benefits expected to be derived from the acquisition. The goodwill related to Western Polymer is tax-deductible due to the structure of the acquisition.

Pro-forma results of operations for the acquisition made in 2019 have not been presented as the effect of the acquisition would not be material to the Company’s results of operations for any periods presented.

XML

Revenue Recognition

6 Months Ended

Jun. 30, 2020

Revenue Recognition

Revenue Recognition

4. Revenue Recognition

The Company applies the provisions of Accounting Standards Codification (“ASC”) 606-10, Revenue from Contracts with Customers. The Company recognizes revenue under the core principle to depict the transfer of products to customers in an amount reflecting the consideration the Company expects to receive. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

The Company identified customer purchase orders, which in some cases are governed by a master sales agreement, as the contracts with its customers. For each contract, the Company considers the transfer of products, each of which is distinct, to be the identified performance obligation. In determining the transaction price for the performance

obligation, the Company evaluates whether the price is subject to adjustment to determine the consideration to which the Company expects to be entitled. The pricing model can be fixed or variable within the contract. The variable pricing model is based on historical commodity pricing and is determinable prior to completion of the performance obligation. Additionally, the Company has certain sales adjustments for volume incentive discounts and other discount arrangements that reduce the transaction price. The reduction of the transaction price is estimated using the expected value method based on an analysis of historical volume incentives or discounts, over a period of time considered adequate to account for current pricing and business trends. Historically, actual volume incentives and discounts relative to those estimated and included when determining the transaction price have not materially differed. Volume incentives and discounts are accrued at the satisfaction of the performance obligation and accounted for in Accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheets. These amounts are not significant as of June 30, 2020 or December 31, 2019. The product price as specified in the contract, net of any discounts, is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Payment is received shortly after the performance obligation is satisfied; therefore, the Company has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component.

Revenue is recognized when the Company’s performance obligation is satisfied and control is transferred to the customer, which occurs at a point in time, either upon delivery to an agreed upon location or to the customer. Further, in determining whether control has transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer.

Shipping and handling activities related to contracts with customers represent fulfillment costs and are recorded in Cost of sales. Taxes assessed by governmental authorities and collected from customers are accounted for on a net basis and excluded from revenues.  The Company applies a practical expedient to expense costs to obtain a contract as incurred as most contracts are one year or less. These costs primarily include the Company’s internal sales force compensation. Under the terms of these programs, these are generally earned and the costs are recognized at the time the revenue is recognized.

From time to time, the Company may enter into long-term contracts with its customers. Historically, the contracts entered into by the Company do not result in significant contract assets or liabilities.  Any such arrangements are accounted for in Other assets or Accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheets.  There were no significant contract assets or liabilities as of June 30, 2020 or December 31, 2019.

The Company is principally engaged in the production and sale of starches and sweeteners for a wide range of industries, and is managed geographically on a regional basis. The Company’s operations are classified into four reportable business segments: North America, South America, Asia-Pacific and Europe, Middle East and Africa (“EMEA”).  The nature, amount, timing and uncertainty of the Company’s Net sales are managed by the Company primarily based on its geographic segments. Each region’s product sales are unique to each region and have unique risks.

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Net sales to unaffiliated customers:
North America	$	848	$	977	$	1,811	$	1,928
South America		182		226		419		454
Asia-Pacific		187		203		376		406
EMEA		132		144		286		298
Total net sales	$	1,349	$	1,550	$	2,892	$	3,086

XML

Restructuring and Impairment Charges

6 Months Ended

Jun. 30, 2020

Restructuring and Impairment Charges

Restructuring and Impairment Charges

5. Restructuring and Impairment Charges

For the three and six months ended June 30, 2020, the Company recorded a total of $11 million and $25 million of pre-tax restructuring charges, respectively, as part of the Cost Smart program. For the three months ended June 30, 2020, the Company recorded $6 million of pre-tax restructuring charges for its Cost Smart cost of sales program, including $3 million of asset write-offs and $1 million of other costs in relation to the closure of the Lane Cove, Australia production facility. During the three months ended June 30, 2020, the Company also recorded $1 million of accelerated depreciation and $1 million of employee-related severance, primarily in North America. For the six months ended June 30, 2020, the Company recorded $15 million of pre-tax restructuring charges for its Cost Smart cost of sales program, including $6

million of asset write-offs, $2 million of other costs, and $1 million of accelerated depreciation in relation to the closure of the Lane Cove, Australia production facility. The Company expects to incur $2 million of additional restructuring costs during the remainder of 2020 related to the Lane Cove production facility closure. During the six months ended June 30, 2020, the Company also recorded $4 million of accelerated depreciation, $1 million of employee-related severance, and $1 million of other costs, primarily in North America.

Additionally, the Company recorded pre-tax restructuring charges of $5 million and $10 million during the three and six months ended June 30, 2020, respectively, for its Cost Smart selling, general and administrative expense (“SG&A”) program. During the three months ended June 30, 2020, the Company recorded $5 million of pre-tax restructuring charges, consisting primarily of other costs, including professional services, in North America. During the six months ended June 30, 2020, the Company recorded pre-tax restructuring costs of $10 million primarily in North America, consisting of $8 million of other costs, including professional services, and $2 million of employee-related severance.

For the three and six months ended June 30, 2019, the Company recorded $9 million and $13 million of pre-tax restructuring charges, respectively.  For the three and six months ended June 30, 2019, the Company recorded $6 million and $9 million, respectively, of other costs, including professional services, and employee-related severance in the North America and South America segments as part of its Cost Smart SG&A program. This included $1 million and $2 million of other costs associated with the Finance Transformation initiative in Latin America for the three and six months ended June 30, 2019, respectively. Additionally, for the three and six months ended June 30, 2019, the Company recorded $3 million and $4 million, respectively, of other costs, including professional services, as part of the Cost Smart cost of sales program, including $1 million and $2 million, respectively, in relation to the prior year cessation of wet-milling at the Stockton, California plant.

A summary of the Company’s employee-related severance accrual as of June 30, 2020 is as follows (in millions):

Balance in severance accrual as of December 31, 2019	$	15
Cost Smart cost of sales and SG&A		3
Payments made to terminated employees		(9)
Foreign exchange translation		(1)
Balance in severance accrual as of June 30, 2020	$	8

Of the $8 million severance accrual as of June 30, 2020, $7 million is expected to be paid in the next 12 months.

As of June 30, 2020, the Company identified certain assets within the Stockton, California and Lane Cove, Australia locations that met the held for sale criteria. The Company expects to sell these assets at a fair value equal to or greater than the carrying value as of June 30, 2020, and did not record a gain or loss associated with the reclassification of these assets to held for sale for the six months ended June 30, 2020. The assets classified as held for sale are reflected in the Condensed Consolidated Balance Sheets as follows:

(in millions)		June 30, 2020		December 31, 2019
Other assets	$	13	$	—

XML

Financial Instruments, Derivatives and Hedging Activities

6 Months Ended

Jun. 30, 2020

Financial Instruments, Derivatives and Hedging Activities

Financial Instruments, Derivatives and Hedging Activities

6. Financial Instruments, Derivatives and Hedging Activities

The Company is exposed to market risk stemming from changes in commodity prices (primarily corn and natural gas), foreign currency exchange rates and interest rates. In the normal course of business, the Company actively manages its exposure to these market risks by entering into various hedging transactions, authorized under established policies that place controls on these activities. These transactions utilize exchange-traded derivatives or over-the-counter derivatives with investment grade counterparties. Derivative financial instruments currently used by the Company consist of commodity-related futures, options and swap contracts, foreign currency-related forward contracts, interest rate swaps, and treasury locks (“T-Locks”).

Commodity price hedging: The Company’s principal use of derivative financial instruments is to manage commodity price risk relating to anticipated purchases of corn and natural gas to be used in the manufacturing process, generally over the next 12 to 24 months. The Company maintains a commodity-price risk management strategy that uses derivative instruments to minimize significant, unanticipated earnings fluctuations caused by commodity-price volatility.

To manage price risk related to corn purchases primarily in North America, the Company uses corn futures and option contracts that trade on regulated commodity exchanges to lock-in corn costs associated with fixed-priced customer sales contracts. The Company also uses over-the-counter natural gas swaps in North America to hedge a portion of its natural gas usage. These derivative financial instruments limit the impact that volatility resulting from fluctuations in market prices will have on corn and natural gas purchases. The Company’s natural gas derivatives and the majority of its corn derivatives have been designated as cash flow hedging instruments.

The Company enters into certain corn derivative instruments that are not designated as hedging instruments as defined by ASC 815, Derivatives and Hedging. Therefore, the realized and unrealized gains and losses from these instruments are recognized in cost of sales during each accounting period. These derivative instruments also mitigate commodity price risk related to anticipated purchases of corn.

For commodity hedges designated as cash flow hedges, unrealized gains and losses associated with marking the commodity hedging contracts to market (fair value) are recorded as a component of other comprehensive income (“OCI”) and included in the equity section of the Condensed Consolidated Balance Sheets as part of Accumulated other comprehensive income (“AOCI”). These amounts are subsequently reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings, or in the month a hedge is determined to be ineffective. The Company assesses the effectiveness of a commodity hedge contract based on changes in the contract’s fair value. The changes in the market value of such contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in the price of the hedged items. Gains and losses from cash flow hedging instruments reclassified from AOCI to earnings are reported as Cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.

As of June 30, 2020, the Company had outstanding futures and option contracts that hedged the forecasted purchase of approximately 64 million bushels of corn. The Company had outstanding swap and option contracts that hedged the forecasted purchase of approximately 33 million mmbtu’s of natural gas at June 30, 2020.

Foreign currency hedging: Due to the Company’s global operations, including operations in many emerging markets, the Company is exposed to fluctuations in foreign currency exchange rates. As a result, the Company has exposure to translational foreign-exchange risk when the results of its foreign operations are translated to U.S. dollars and to transactional foreign-exchange risk when transactions not denominated in the functional currency are revalued. The Company’s foreign-exchange risk management strategy uses derivative financial instruments such as foreign currency forward contracts, swaps and options to manage its transactional foreign exchange risk. The Company enters into foreign currency derivative instruments that are designated as both cash flow hedging instruments as well as instruments not designated as hedging instruments as defined by ASC 815, Derivatives and Hedging, in order to mitigate transactional foreign-exchange risk. Gains and losses from derivative financial instruments not designated as hedging instruments are marked to market in earnings during each accounting period.

The Company hedges certain assets using foreign currency derivatives not designated as hedging instruments, which had a notional value of $590 million and $621 million as of June 30, 2020 and December 31, 2019, respectively. The Company also hedges certain liabilities using foreign currency derivatives not designated as hedging instruments, which had a notional value of $478 million and $356 million as of June 30, 2020 and December 31, 2019, respectively.  

The Company hedges certain assets using foreign currency cash flow hedging instruments, which had a notional value of $325 million and $374 million as of June 30, 2020 and December 31, 2019, respectively. The Company also hedges certain liability positions using foreign currency cash flow hedging instruments, which had a notional value of $460 million and $541 million as of June 30, 2020 and December 31, 2019, respectively.

Interest rate hedging: The Company assesses its exposure to variability in interest rates by identifying and monitoring changes in interest rates that may adversely impact future cash flows and the fair value of existing debt instruments, and by evaluating hedging opportunities. The Company’s risk management strategy is to monitor interest rate risk attributable to both the Company’s outstanding and forecasted debt obligations as well as the Company’s offsetting hedge positions. Derivative financial instruments that have been used by the Company to manage its interest rate risk consist of interest rate swaps and T-Locks.

The Company periodically enters into interest rate swaps to hedge its exposure to interest rate changes. The changes in fair value of interest rate swaps designated as hedging instruments that effectively offset the variability in the

fair value of outstanding debt obligations are reported in earnings. These amounts offset the gains or losses (the changes in fair value) of the hedged debt instruments that are attributable to changes in interest rates (the hedged risk), which are also recognized in earnings. As of June 30, 2020, the Company did not have any outstanding interest rate swaps. As of December 31, 2019, the Company had an outstanding interest rate swap agreement that converted the interest rates on $200 million of its $400 million 4.625% senior notes due November 1, 2020, to variable rates.

The Company periodically enters into T-Locks to hedge its exposure to interest rate changes. The T-Locks are designated as hedges of the variability in cash flows associated with future interest payments caused by market fluctuations in the benchmark interest rate until the fixed interest rate is established, and are accounted for as cash flow hedges. Accordingly, changes in the fair value of the T-Locks are recorded to AOCI until the consummation of the underlying debt offering, at which time any realized gain (loss) is amortized to earnings over the life of the debt. The Company did not have outstanding T-locks as of June 30, 2020, or December 31, 2019.

The derivative instruments designated as cash flow hedges included in AOCI as of June 30, 2020 and December 31, 2019 are reflected below:

Derivatives in Cash Flow Hedging Relationships	Gains (Losses) included in AOCI
(in millions)	June 30, 2020		December 31, 2019
Commodity contracts, net of income tax effect of $13 and $5, respectively	$	(36)	$	(11)
Foreign currency contracts, net of income tax effect of $ — and $1, respectively		—		3
Interest rate contracts, net of income tax effect of $1 and $ — , respectively		(4)		(1)
Total	$	(40)	$	(9)

The fair value and balance sheet location of the Company’s derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are reflected below:

	Fair Value of Hedging Instruments as of June 30, 2020
	Designated Hedging Instruments (in millions)								Non-Designated Hedging Instruments (in millions)
Balance Sheet Location		Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total			Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total
Accounts receivable, net	$	3	$	—	$	—	$	3	$	—	$	5	$	—	$	5
Other assets		2		1		—		3		—		1		—		1
Assets		5		1		—		6		—		6		—		6
Accounts payable and accrued liabilities		26		2		—		28		4		16		—		20
Non-current liabilities		2		—		—		2		—		3		—		3
Liabilities		28		2		—		30		4		19		—		23
Net (Liabilities)/Assets	$	(23)	$	(1)	$	—	$	(24)	$	(4)	$	(13)	$	—	$	(17)

	Fair Value of Hedging Instruments as of December 31, 2019
	Designated Hedging Instruments (in millions)								Non-Designated Hedging Instruments (in millions)
Balance Sheet Location		Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total			Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total
Accounts receivable, net	$	5	$	7	$	—	$	12	$	2	$	4	$	—	$	6
Other assets		1		3		1		5		—		1		—		1
Assets		6		10		1		17		2		5		—		7
Accounts payable and accrued liabilities		13		4		—		17		1		8		—		9
Non-current liabilities		4		4		—		8		—		2		—		2
Liabilities		17		8		—		25		1		10		—		11
Net (Liabilities)/Assets	$	(11)	$	2	$	1	$	(8)	$	1	$	(5)	$	—	$	(4)

Additional information pertaining to the Company’s fair value hedges is presented below:

Line item in the statement of financial position in which the hedged item is included (in millions)	Carrying Amount of the Hedged Assets/(Liabilities)				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of Hedged Assets/(Liabilities)
Balance sheet date as of	June 30, 2020		December 31, 2019		June 30, 2020		December 31, 2019
Interest Rate Contracts:
Long-Term Debt	$	—	$	(201)	$	—	$	(1)

Additional information relating to the Company’s derivative instruments is presented below:

Derivatives in Cash Flow	Gains (Losses) Recognized  in OCI on Derivatives				Income	Gains (Losses) Reclassified from AOCI into Income
Hedging Relationships	Three Months Ended June 30,				Statement	Three Months Ended June 30,
(in millions)	2020		2019		Location	2020		2019
Commodity contracts	$	(20)	$	10	Cost of sales	$	(17)	$	(5)
Foreign currency contracts		1		3	Net sales/Cost of sales		(1)		1
Interest rate contracts		(1)		—	Financing costs, net		(1)		—
Total	$	(20)	$	13		$	(19)	$	(4)

Derivatives in Cash-Flow	Gains (Losses) Recognized  in OCI on Derivatives				Income	Gains (Losses) Reclassified from AOCI into Income
Hedging Relationships	Six Months Ended June 30,				Statement	Six Months Ended June 30,
(in millions, pre-tax)	2020		2019		Location	2020		2019
Commodity contracts	$	(57)	$	—	Cost of sales	$	(24)	$	(3)
Foreign currency contracts		(4)		1	Net sales/Cost of sales		—		(2)
Interest rate contracts		(5)		—	Financing costs, net		(1)		(1)
Total	$	(66)	$	1		$	(25)	$	(6)

Derivatives in Fair Value Hedging	Income Statement Location of	Gains (Losses) Recognized in Income				Income Statement	Gains (Losses) Recognized in Income
Relationships	Derivatives Designated as	Three Months Ended June 30,				Location	Three Months Ended June 30,
(in millions)	Hedging Instruments	2020		2019		of Hedged Items	2020		2019
Interest rate contracts	Financing costs, net	$	(4)	$	3	Financing costs, net	$	4	$	(3)

Derivatives in Fair Value	Income Statement Location of	Gains (Losses) Recognized in Income				Income Statement	Gains (Losses) Recognized in Income
Hedging Relationships	Derivatives Designated as	Six Months Ended June 30,				Location	Six Months Ended June 30,
(in millions)	Hedging Instruments	2020		2019		of Hedged Items	2020		2019
Interest rate contracts	Financing costs, net	$	(1)	$	3	Financing costs, net	$	1	$	(3)

As of June 30, 2020, AOCI included $36 million of net losses (net of income taxes of $13 million) on settled commodities-related derivatives instruments, T-Locks, and foreign currency hedges designated as cash flow hedges that are expected to be reclassified into earnings during the next 12 months.

Fair Value Measurements: Presented below are the fair values of the Company’s financial instruments and derivatives for the periods presented:

	As of June 30, 2020								As of December 31, 2019
(in millions)	Total		Level 1 (a)		Level 2 (b)		Level 3 (c)		Total		Level 1 (a)		Level 2 (b)		Level 3 (c)
Available for sale securities	$	10	$	10	$	—	$	—	$	13	$	13	$	—	$	—
Derivative assets		12		2		10		—		24		7		17		—
Derivative liabilities		53		21		32		—		36		5		31		—
Long-term debt		2,215		—		2,215		—		1,751		—		1,751		—

(a) Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities.

(b) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 2 inputs are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data.  

(c) Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

The carrying values of cash equivalents, short-term investments, accounts receivable, accounts payable and short-term borrowings approximate fair values. Commodity futures, options, and swap contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of the Company’s Long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities. As of June 30, 2020, the carrying value and fair value of the Company’s Long-term debt was $2.1 billion and $2.2 billion, respectively.

XML

Debt

6 Months Ended

Jun. 30, 2020

Debt

Debt

7. Debt

As of June 30, 2020 and December 31, 2019, the Company’s total debt consisted of the following:

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
2.900% senior notes due June 1, 2030	$	594	$	—
3.200% senior notes due October 1, 2026		497		497
3.900% senior notes due June 1, 2050		390		—
6.625% senior notes due April 15, 2037		253		253
4.625% senior notes due November 1, 2020		—		400
5.62% senior notes due March 25, 2020		—		200
Term loan credit agreement due April 12, 2021		405		405
Revolving credit facility		—		10
Other long-term borrowings		1		—
Fair value adjustment related to hedged fixed rate debt instruments		—		1
Long-term debt		2,140		1,766
4.625% senior notes due November 1, 2020		400		—
Other short-term borrowings		70		82
Short-term debt		470		82
Total debt	$	2,610	$	1,848

During the three months ended March 31, 2020, the Company used proceeds from the revolving credit facility (“Revolving Credit Facility”) to refinance $200 million of its 5.62% senior notes due March 25, 2020.

During the three months ended June 30, 2020, the Company sold its (i) 2.900% senior notes due 2030 in the principal amount of $600 million (the “2030 Notes”) and (ii) 3.900% senior notes due 2050 in the principal amount of $400 million (the “2050 Notes” and, together with the “2030 Notes,” the “Notes”).  The Company recorded the aggregate discount of approximately $7 million at which the Notes were issued and capitalized debt issuance costs of approximately $9 million associated with the Notes.

During the three months ended June 30, 2020, the Company applied the net proceeds from the sale of the Notes to pay in full the outstanding balance of $394 million under the Revolving Credit Facility and to set aside funds to repay its 4.625% senior notes due November 1, 2020 (the “2020 Notes”).  On June 8, 2020, the Company issued a notice for the redemption in full of all $400 million principal amount of the 2020 Notes.  The 2020 Notes were redeemed on July 9, 2020 for a total redemption price of $409 million, including accrued interest and a “make-whole” premium as set forth in the indenture.

The Company’s long-term debt as of June 30, 2020, includes the term loan credit agreement due April 12, 2021, as the Company has the ability and intent to refinance it on a long-term basis using our Revolving Credit Facility or other means prior to the maturity date.

XML

Leases

6 Months Ended

Jun. 30, 2020

Leases

Leases

8. Leases

The Company determines if an arrangement is a lease at inception of the agreement. Operating leases are included in operating lease assets, and current and non-current operating lease liabilities in the Company’s Condensed Consolidated Balance Sheets. Lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease asset value includes in its calculation any prepaid lease payments made and any lease incentives received from the arrangement as a reduction of the asset.  The Company’s lease terms may include options to extend or terminate the lease, and the impact of these options is included in the lease liability and lease asset calculations when the exercise of the option is at the Company’s sole discretion and it is reasonably certain that the Company will exercise that option. The Company will not separate lease and non-lease components for its leases when it is impracticable to separate the two, such as for leases with variable payment arrangements. Leases with an initial term of 12 months or less are not recorded on the balance sheet.

The Company has operating leases for certain rail cars, office space, warehouses, and machinery and equipment.  The commencement date used for the calculation of the lease obligations recorded is the latter of the commencement date of the new standard (January 1, 2019) or the lease start date.  Certain of the leases have options to extend the life of the lease, which are included in the liability calculation when the option is at the sole discretion of the Company and it is reasonably certain that the Company will exercise the option.  The Company has certain leases that have variable payments based solely on output or usage of the leased asset.  These variable operating lease assets are excluded from the Company’s balance sheet presentation and expensed as incurred.  The Company currently has no finance leases.

Lease expense for lease payments is recognized on a straight-line basis over the lease term. The components of lease expense were as follows:

	Three Months Ended				Six Months Ended
Lease Cost	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Operating lease cost	$	13	$	14	$	26	$	27
Variable operating lease cost		7		6		15		12
Short term lease cost		1		1		2		1
Lease cost	$	21	$	21	$	43	$	40

The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities and the related operating lease assets as presented on the Condensed Consolidated Balance Sheet as of June 30, 2020.

Operating Leases		As of
(in millions)		June 30, 2020
2020 (Excluding the six months ended June 30, 2020)	$	26
2021		44
2022		35
2023		26
2024		18
Thereafter		34
Total future lease payments		183
Less imputed interest		27
Present value of future lease payments		156
Less current lease liabilities		41
Non-current operating lease liabilities	$	115
Operating lease assets	$	149

Additional information related to the Company’s operating leases is listed below.

	Three Months Ended				Six Months Ended
Other Information	June 30,				June 30,
($ in millions)	2020		2019		2020			2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	13	$	14	$	26		$	29
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases	$	13	$	6	$	21		$	167
					As of			As of
					June 30, 2020			December 31, 2019
Weighted average remaining lease term:
Operating leases						5.2 years			5.5 years
Weighted average discount rate:
Operating leases						5.5	%		5.7	%

XML

Taxes

6 Months Ended

Jun. 30, 2020

Taxes

Taxes

9. Taxes

The Company’s effective tax rate for the three months ended June 30, 2020 decreased to 28.7 percent from 29.6 percent during the three months ended June 30, 2019.  The decrease in the effective income tax rate was primarily driven by a reduction in the Company’s U.S. global intangible low-taxed income (“GILTI”), an adjustment for inflation in Mexico and utilization of previously unbenefited net operating losses compared to an increase in valuation allowance in the 2019 period.  The decrease was partially offset by an increase in Argentine hyperinflation adjustments.

The effective tax rate for the six months ended June 30, 2020 was 37.0 percent compared to 28.2 percent during the six months ended June 30, 2019. The increase in the effective tax rate was driven by a 22 percent decrease in the valuation of the Mexican peso against the U.S. dollar during the six months ended June 30, 2020.  Because the Company uses the U.S. dollar as the functional currency for its subsidiaries in Mexico, its effective tax rate is strongly influenced by the remeasurement of the Mexican peso financial statements into U.S. dollars.  In addition, the decrease in the valuation of the Mexican peso against the U.S. dollar produced taxable translation gains on net-U.S.-dollar-monetary assets held in Mexico for which there was no corresponding gain in pre-tax income.  Consequently, the Company recorded a discrete tax expense of $22 million in the six months ended June 30, 2020, as compared to a $1 million discrete tax benefit in the six months ended June 30, 2019.

XML

Net Periodic Pension and Postretirement Benefit Costs

6 Months Ended

Jun. 30, 2020

Net Periodic Pension and Postretirement Benefit Costs

Net Periodic Pension and Postretirement Benefit Costs

10. Net Periodic Pension and Postretirement Benefit Costs

The following table sets forth the components of net periodic benefit cost of the U.S. and non-U.S. defined benefit pension plans for the periods presented:

	Three Months Ended June 30,								Six Months Ended June 30,
	U.S. Plans				Non-U.S. Plans				U.S. Plans				Non-U.S. Plans
(in millions)	2020		2019		2020		2019		2020		2019		2020		2019
Service cost	$	1	$	1	$	1	$	1	$	2	$	2	$	2	$	2
Interest cost		3		3		3		2		6		7		6		5
Expected return on plan assets		(6)		(4)		(2)		(2)		(11)		(9)		(4)		(4)
Amortization of actuarial loss		—		—		1		1		—		—		1		1
Net periodic benefit cost (a)	$	(2)	$	—	$	3	$	2	$	(3)	$	—	$	5	$	4

The Company currently anticipates that it will make approximately $4 million in cash contributions to its pension plans in 2020, consisting of $3 million to its non-U.S. pension plans and $1 million to its U.S. pension plans. For the six months ended June 30, 2020, cash contributions of approximately $1 million were made to the non-U.S. plans and an insignificant amount to the U.S. plans.

The following table sets forth the components of net postretirement benefit cost for the periods presented:

	Three Months Ended June 30,				Six Months Ended June 30,
(in millions)	2020		2019		2020		2019
Service cost	$	—	$	—	$	—	$	—
Interest cost		1		—		2		1
Amortization of prior service credit		—		—		(1)		(1)
Net periodic benefit cost (a)	$	1	$	—	$	1	$	—

(a) The service cost component of net periodic benefit cost is presented within either cost of sales or operating expenses on the Condensed Consolidated Statements of Income. The interest cost, expected return on plan assets, amortization of prior service credit, and amortization of actuarial loss components of net periodic benefit cost are presented as other, non-operating income on the Condensed Consolidated Statements of Income.

XML

Inventories

6 Months Ended

Jun. 30, 2020

Inventories

Inventories

11. Inventories

Inventories are summarized as follows:

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
Finished and in process	$	552	$	565
Raw materials		246		237
Manufacturing supplies and other		61		59
Total inventories	$	859	$	861

XML

Equity

6 Months Ended

Jun. 30, 2020

Equity

Equity

12. Equity

Treasury stock: On October 22, 2018, the Board of Directors authorized a new stock repurchase program permitting the Company to purchase up to 8 million of its outstanding common shares from November 5, 2018 through December 31, 2023.  The parameters of the Company’s stock repurchase program are not established solely with reference to the dilutive impact of shares issued under the Company’s stock incentive plan. However, the Company expects that, over time, share repurchases will offset the dilutive impact of shares issued under the stock incentive plan.

On November 5, 2018, the Company entered into a Variable Timing Accelerated Share Repurchase (“ASR”) program with JPMorgan (“JPM”).  Under the ASR program, the Company paid $455 million on November 5, 2018, and acquired 4 million shares of its common stock having an approximate value of $423 million on that date.  On February 5, 2019, the Company and JPM settled the difference between the initial price and average daily volume weighted average price (“VWAP”) less the agreed upon discount during the term of the ASR agreement.  The final VWAP was $98.04 per share, which was less than originally paid.  The Company settled the difference in cash, resulting in JPM returning $63

million of the upfront payment to the Company on February 6, 2019, and lowering the total cost of repurchasing the 4 million shares of common stock to $392 million.  The Company adjusted Additional paid-in capital and Treasury stock by $32 million and $31 million, respectively, during the six months ended June 30, 2019 for this inflow of cash. In the three and six months ended June 30, 2020, the Company did not repurchase shares of common stock.

Shared-based payments: The following table summarizes the components of the Company’s share-based compensation expense:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Stock options:
Pre-tax compensation expense	$	1	$	1	$	2	$	2
Income tax benefit		—		—		—		—
Stock option expense, net of income taxes		1		1		2		2
Restricted stock units ("RSUs"):
Pre-tax compensation expense		3		3		6		5
Income tax benefit		—		(1)		(1)		(1)
RSUs, net of income taxes		3		2		5		4
Performance shares and other share-based awards:
Pre-tax compensation expense		2		2		4		3
Income tax benefit		—		—		—		—
Performance shares and other share-based compensation expense, net of income taxes		2		2		4		3
Total share-based compensation:
Pre-tax compensation expense		6		6		12		10
Income tax benefit		—		(1)		(1)		(1)
Total share-based compensation expense, net of income taxes	$	6	$	5	$	11	$	9

Stock Options: Under the Company’s stock incentive plan, stock options are granted at exercise prices that equal the market value of the underlying common stock on the date of grant. The options have a 10-year term and are exercisable upon vesting, which occurs over a three-year period at the anniversary dates of the date of grant. Compensation expense is generally recognized on a straight-line basis for all awards over the employee’s vesting period or over a one-year required service period for certain retirement-eligible executive level employees. The Company estimates a forfeiture rate at the time of grant and updates the estimate throughout the vesting period of the stock options within the amount of compensation costs recognized in each period.

The Company granted non-qualified options to purchase 336 thousand shares and 247 thousand shares for the six months ended June 30, 2020 and 2019, respectively. The fair value of each option grant was estimated using the Black-Scholes option-pricing model with the following assumptions at the date of grant:

	Six Months Ended June 30,
	2020		2019
Expected life (in years)	5.5		5.5
Risk-free interest rate	1.4	%	2.5	%
Expected volatility	19.8	%	19.7	%
Expected dividend yield	2.9	%	2.7	%

The expected life of options represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting schedules and the Company’s historical exercise patterns. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date for the period corresponding to the expected life of the options. Expected volatility is based on historical volatilities of the Company’s common stock. Dividend yield is based on current dividend payments at the date of grant.

Stock option activity for the six months ended June 30, 2020 was as follows:

	Number of Options (in thousands)	Weighted Average Exercise Price per Share		Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019	2,055	$	84.36	5.30	$	34
Granted	336		88.35
Exercised	(91)		45.01
Cancelled	(7)		81.09
Outstanding as of June 30, 2020	2,293	$	86.53	5.64	$	15
Exercisable as of June 30, 2020	1,742	$	84.05	4.58	$	15

For the six months ended June 30, 2020, cash received from the exercise of stock options was $5 million. As of June 30, 2020, the unrecognized compensation cost related to non-vested stock options totaled $4 million, which is expected to be amortized over the weighted-average period of approximately 1.7 years.

Additional information pertaining to stock option activity is as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(dollars in millions, except per share)	2020		2019		2020		2019
Weighted average grant date fair value of stock options granted (per share)	$	—	$	—	$	11.48	$	14.02
Total intrinsic value of stock options exercised	$	—	$	2	$	4	$	6

Restricted Stock Units: The Company has granted RSUs to certain key employees. The RSUs are subject to cliff vesting, generally after three years provided the employee remains in the service of the Company. Compensation expense is generally recognized on a straight-line basis for all awards over the employee’s vesting period or over a one-year required service period for certain retirement-eligible executive level employees. The Company estimates a forfeiture rate at the time of grant and updates the estimate throughout the vesting period of the RSUs within the amount of compensation costs recognized in each period. The fair value of the RSUs is determined based upon the number of shares granted and the market price of the Company’s common stock on the date of the grant.

The following table summarizes RSU activity for the six months ended June 30, 2020:

(RSUs in thousands)	Number of Restricted Shares	Weighted Average Fair Value per Share
Non-vested as of December 31, 2019	339	$	108.02
Granted	171		88.29
Vested	(92)		117.25
Cancelled	(12)		104.34
Non-vested as of June 30, 2020	406	$	97.75

As of June 30, 2020, the total remaining unrecognized compensation cost related to RSUs was $21 million, which will be amortized over a weighted average period of approximately 2.0 years.

Performance Shares: The Company has a long-term incentive plan for senior management in the form of performance shares. Historically these performance shares vested based solely on the Company’s total shareholder return as compared to the total shareholder return of its peer group over the three-year vesting period. Beginning with the 2019 performance share grants, the vesting of the performance shares are based on two performance metrics. Fifty percent of the performance shares awarded will vest based on the Company’s total shareholder return as compared to the total shareholder return of its peer group, and the remaining fifty percent will vest based on the calculation of the Company’s three-year average Return on Invested Capital (“ROIC”) against an established ROIC target.

For the 2020 performance shares awarded based on the Company’s total shareholder return, the number of shares that ultimately vest can range from zero to 200 percent of the awarded grant depending on the Company’s total shareholder return as compared to the total shareholder return of its peer group. The share award vesting will be calculated at the end

of the three-year period and is subject to approval by management and the Compensation Committee of the Board of Directors. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. The total compensation expense for these awards is amortized over a three-year graded vesting schedule.

For the 2020 performance shares awarded based on ROIC, the number of shares that ultimately vest can range from zero to 200 percent of the awarded grant depending on the Company’s ROIC performance against the target. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee. Compensation expense is based on the market price of the Company’s common stock on the date of the grant and the final number of shares that ultimately vest.  The Company will estimate the potential share vesting at least annually to adjust the compensation expense for these awards over the vesting period to reflect the Company’s estimated ROIC performance versus the target. The total compensation expense for these awards is amortized over a three-year graded vesting schedule.

For the six months ended June 30, 2020, the Company awarded 81 thousand performance shares at a weighted average fair value of $94.48 per share.

As of June 30, 2020, the unrecognized compensation cost related to these awards was $8 million, which will be amortized over the remaining requisite service period of 2.2 years.

The 2017 performance share awards vested during the six months ended June 30, 2020, achieving a zero percent payout of the granted performance shares.  Additionally, there were zero performance share cancellations during the six months ended June 30, 2020.

Accumulated Other Comprehensive Loss: The following is a summary of net changes in Accumulated other comprehensive loss by component and net of tax for the six months ended June 30, 2020 and 2019:

(in millions)	Cumulative Translation Adjustment		Deferred (Loss) Gain on Hedging Activities		Pension and Postretirement Adjustment		Accumulated Other Comprehensive Loss
Balance, December 31, 2019	$	(1,089)	$	(9)	$	(60)	$	(1,158)
Other comprehensive loss before reclassification adjustments		(118)		(66)		—		(184)
Amount reclassified from accumulated OCI		—		25		—		25
Tax benefit		—		10		—		10
Net other comprehensive loss		(118)		(31)		—		(149)
Balance, June 30, 2020	$	(1,207)	$	(40)	$	(60)	$	(1,307)

(in millions)	Cumulative Translation Adjustment		Deferred (Loss) Gain on Hedging Activities		Pension and Postretirement Adjustment		Accumulated Other Comprehensive Loss
Balance, December 31, 2018	$	(1,080)	$	(5)	$	(69)	$	(1,154)
Other comprehensive income (loss) before reclassification adjustments		(3)		1		(1)		(3)
Amount reclassified from accumulated OCI		—		6		—		6
Tax provision		—		(1)		—		(1)
Net other comprehensive income (loss)		(3)		6		(1)		2
Balance, June 30, 2019	$	(1,083)	$	1	$	(70)	$	(1,152)

Supplemental Information: The following Condensed Consolidated Statements of Equity and Redeemable Equity provide the dividends per share for common stock for the periods presented:

	Total Equity														Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2019	$	—	$	1	$	1,137	$	(1,040)	$	(1,158)	$	3,780	$	21	$	31
Net income attributable to Ingredion												75
Net income attributable to non-controlling interests														3
Dividends declared, common stock ($0.63/share)												(42)
Share-based compensation, net of issuance						5		12								(8)
Other comprehensive loss										(164)				(3)
Balance, March 31, 2020	$	—	$	1	$	1,142	$	(1,028)	$	(1,322)	$	3,813	$	21	$	23
Net income attributable to Ingredion												66
Net income attributable to non-controlling interests														1
Dividends declared, common stock ($0.63/share)												(43)
Dividends declared, non-controlling interests														(3)
Share-based compensation, net of issuance						1		1								4
Other comprehensive income										15				1
Balance, June 30, 2020	$	—	$	1	$	1,143	$	(1,027)	$	(1,307)	$	3,836	$	20	$	27

	Total Equity														Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2018	$	—	$	1	$	1,096	$	(1,091)	$	(1,154)	$	3,536	$	20	$	37
Net income attributable to Ingredion												100
Net income attributable to non-controlling interests														2
Dividends declared, common stock ($0.625/share)												(42)
Repurchases of common stock						32		31
Share-based compensation, net of issuance						9		10								(16)
Other comprehensive loss										(6)
Balance, March 31, 2019	$	—	$	1	$	1,137	$	(1,050)	$	(1,160)	$	3,594	$	22	$	21
Net income attributable to Ingredion												105
Net income attributable to non-controlling interests														2
Dividends declared, common stock ($0.625/share)												(43)
Dividends declared, non-controlling interests														(4)
Share-based compensation, net of issuance						1		3								4
Other comprehensive income (loss)										8				(4)
Balance, June 30, 2019	$	—	$	1	$	1,138	$	(1,047)	$	(1,152)	$	3,656	$	16	$	25

Supplemental Information: The following table provides the computation of basic and diluted earnings per common share ("EPS") for the periods presented:

	Three Months Ended June 30, 2020					Three Months Ended June 30, 2019
(in millions, except per share amounts)	Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount		Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount
Basic EPS	$	66	67.2	$	0.98	$	105	66.9	$	1.57
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards			0.4					0.5
Diluted EPS	$	66	67.6	$	0.98	$	105	67.4	$	1.56

	Six Months Ended June 30, 2020					Six Months Ended June 30, 2019
(in millions, except per share amounts)	Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount		Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount
Basic EPS	$	141	67.2	$	2.10	$	205	66.9	$	3.06
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards			0.5					0.5
Diluted EPS	$	141	67.7	$	2.08	$	205	67.4	$	3.04

For the three and six months ended June 30, 2020 approximately 1.6 million and 1.3 million share-based awards of common stock, respectively, were excluded from the calculation of diluted EPS as the impact of their inclusion would have been anti-dilutive. For the three and six months ended June 30, 2019, approximately 1.0 million and 1.0 million share-based awards of common stock, respectively, were excluded from the calculation of diluted EPS as the impact of their inclusion would have been anti-dilutive.

XML

Segment Information

6 Months Ended

Jun. 30, 2020

Segment Information

Segment Information

13. Segment Information

The Company is principally engaged in the production and sale of starches and sweeteners for a wide range of industries, and is managed geographically on a regional basis. The Company’s operations are classified into four reportable business segments: North America, South America, Asia-Pacific, and EMEA.  Its North America segment includes businesses in the U.S., Mexico, and Canada. The Company’s South America segment includes businesses in Brazil, Colombia, Ecuador, and the Southern Cone of South America, which includes Argentina, Peru, Chile, and Uruguay. Its Asia-Pacific segment includes businesses in South Korea, Thailand, China, Australia, Japan, Indonesia, Singapore, the Philippines, India, Malaysia, New Zealand, and Vietnam. The Company’s EMEA segment includes businesses in Pakistan, Germany, the United Kingdom, South Africa, and Kenya. The Company does not aggregate its operating segments when determining its reportable segments. Net sales by product are not presented because to do so would be impracticable.

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Net sales to unaffiliated customers:
North America	$	848	$	977	$	1,811	$	1,928
South America		182		226		419		454
Asia-Pacific		187		203		376		406
EMEA		132		144		286		298
Total net sales	$	1,349	$	1,550	$	2,892	$	3,086

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Operating income:
North America	$	101	$	139	$	226	$	264
South America		13		16		39		34
Asia-Pacific		22		23		42		43
EMEA		21		23		48		47
Corporate		(30)		(23)		(61)		(44)
Subtotal		127		178		294		344
Restructuring/impairment charges		(11)		(9)		(25)		(13)
Acquisition/integration costs		(3)		(1)		(3)		(2)
Total operating income	$	113	$	168	$	266	$	329

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
Assets:
North America (a)	$	4,611	$	3,924
South America		647		774
Asia-Pacific		838		843
EMEA		515		499
Total assets	$	6,611	$	6,040

(a) For purposes of presentation, North America includes Corporate assets.

XML

Subsequent Events

6 Months Ended

Jun. 30, 2020

Subsequent Events

Subsequent Events

14. Subsequent Event

On July 1, 2020, the Company completed its acquisition of PureCircle Limited (“PureCircle”) through its wholly owned subsidiary Ingredion SRSS Holdings Limited (“Ingredion SRSS”), an unlisted United Kingdom private limited company. To complete the closing, the Company made a total cash payment of $222 million, which it funded from cash on hand.  Upon the closing, PureCircle is wholly owned by Ingredion SRSS, which in turn is 75%-owned by Ingredion and 25%-owned by former PureCircle shareholders. PureCircle will be consolidated by Ingredion for financial reporting purposes.

XML

Summary of Significant Accounting Standards and Policies (Policies)

6 Months Ended

Jun. 30, 2020

Summary of Significant Accounting Policies

Recently Adopted Accounting Standards and New Accounting Standards

Recently Adopted Accounting Standards

ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350)

In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This Update simplifies the subsequent measurement of goodwill as the Update eliminates Step 2 from the goodwill impairment test. Under the Update, an entity will continue to perform its annual, or interim, goodwill impairment test to determine if the fair value of a reporting unit is greater than its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value using the results of its Step 1 assessment, with the loss recognized not to exceed the total amount of goodwill allocated to that reporting unit. This Update is effective for annual periods beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU 2017-04 at the beginning of its 2020 fiscal year and the Update did not have a material impact on the Company’s Condensed Consolidated Financial Statements upon adoption.

ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326)

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. This Update is effective for annual periods beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU 2016-13 at the beginning of its 2020 fiscal year and the Update did not have a material impact on the Company’s Condensed Consolidated Financial Statements upon adoption.

Net Sales Presentation Change

Net Sales Presentation Change

During the three months ended December 31, 2019, the Company changed its presentation of shipping and handling costs.  These expenses were previously included as a reduction to Net sales in the Condensed Consolidated Statements of Income.  The Company is now presenting these expenses within Cost of sales in the Condensed Consolidated Statements of Income.  The change in presentation was applied retrospectively to all periods presented in the Condensed Consolidated Statements of Income.  The change in presentation had no effect on Gross profit, Operating income, Net income, or Earnings per share.  The Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of

Comprehensive Income (Loss), Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows are not affected by this change in presentation.

The effect of the adjustment is as follows:

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Consolidated Statements of Income:
Net sales before shipping and handling costs	$	1,550	$	—	$	3,086	$	—
Less: shipping and handling costs		116		—		232		—
Net sales		1,434		1,550		2,854		3,086
Cost of sales		1,105		1,221		2,209		2,441
Gross profit	$	329	$	329	$	645	$	645

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Net sales to unaffiliated customers:
North America	$	885	$	977	$	1,745	$	1,928
South America		215		226		433		454
Asia-Pacific		195		203		389		406
EMEA		139		144		287		298
Total	$	1,434	$	1,550	$	2,854	$	3,086

XML

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2020

Summary of Significant Accounting Policies

Schedule of new accounting standards

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Consolidated Statements of Income:
Net sales before shipping and handling costs	$	1,550	$	—	$	3,086	$	—
Less: shipping and handling costs		116		—		232		—
Net sales		1,434		1,550		2,854		3,086
Cost of sales		1,105		1,221		2,209		2,441
Gross profit	$	329	$	329	$	645	$	645

	Three Months Ended June 30, 2019				Six Months Ended June 30, 2019
(in millions)	As Reported		As Adjusted		As Reported		As Adjusted
Net sales to unaffiliated customers:
North America	$	885	$	977	$	1,745	$	1,928
South America		215		226		433		454
Asia-Pacific		195		203		389		406
EMEA		139		144		287		298
Total	$	1,434	$	1,550	$	2,854	$	3,086

XML

Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2020

Revenue Recognition

Schedule of disaggregation of net sales

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Net sales to unaffiliated customers:
North America	$	848	$	977	$	1,811	$	1,928
South America		182		226		419		454
Asia-Pacific		187		203		376		406
EMEA		132		144		286		298
Total net sales	$	1,349	$	1,550	$	2,892	$	3,086

XML

Restructuring and Impairment Charges (Tables)

6 Months Ended

Jun. 30, 2020

Restructuring and Impairment Charges

Summary of restructuring/impairment charges

A summary of the Company’s employee-related severance accrual as of June 30, 2020 is as follows (in millions):

Balance in severance accrual as of December 31, 2019	$	15
Cost Smart cost of sales and SG&A		3
Payments made to terminated employees		(9)
Foreign exchange translation		(1)
Balance in severance accrual as of June 30, 2020	$	8

Summary of assets classified as held for sale reflected in balance sheet

(in millions)		June 30, 2020		December 31, 2019
Other assets	$	13	$	—

XML

Financial Instruments, Derivatives and Hedging Activities (Tables)

6 Months Ended

Jun. 30, 2020

Financial Instruments, Derivatives and Hedging Activities

Schedule of cash flow hedges included in AOCI

Derivatives in Cash Flow Hedging Relationships	Gains (Losses) included in AOCI
(in millions)	June 30, 2020		December 31, 2019
Commodity contracts, net of income tax effect of $13 and $5, respectively	$	(36)	$	(11)
Foreign currency contracts, net of income tax effect of $ — and $1, respectively		—		3
Interest rate contracts, net of income tax effect of $1 and $ — , respectively		(4)		(1)
Total	$	(40)	$	(9)

Schedule of location and amount of assets and liabilities reported in balance sheet

	Fair Value of Hedging Instruments as of June 30, 2020
	Designated Hedging Instruments (in millions)								Non-Designated Hedging Instruments (in millions)
Balance Sheet Location		Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total			Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total
Accounts receivable, net	$	3	$	—	$	—	$	3	$	—	$	5	$	—	$	5
Other assets		2		1		—		3		—		1		—		1
Assets		5		1		—		6		—		6		—		6
Accounts payable and accrued liabilities		26		2		—		28		4		16		—		20
Non-current liabilities		2		—		—		2		—		3		—		3
Liabilities		28		2		—		30		4		19		—		23
Net (Liabilities)/Assets	$	(23)	$	(1)	$	—	$	(24)	$	(4)	$	(13)	$	—	$	(17)

	Fair Value of Hedging Instruments as of December 31, 2019
	Designated Hedging Instruments (in millions)								Non-Designated Hedging Instruments (in millions)
Balance Sheet Location		Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total			Commodity Contracts		Foreign Currency Contracts		Interest Rate Contracts	Total
Accounts receivable, net	$	5	$	7	$	—	$	12	$	2	$	4	$	—	$	6
Other assets		1		3		1		5		—		1		—		1
Assets		6		10		1		17		2		5		—		7
Accounts payable and accrued liabilities		13		4		—		17		1		8		—		9
Non-current liabilities		4		4		—		8		—		2		—		2
Liabilities		17		8		—		25		1		10		—		11
Net (Liabilities)/Assets	$	(11)	$	2	$	1	$	(8)	$	1	$	(5)	$	—	$	(4)

Schedule of fair value hedges

Line item in the statement of financial position in which the hedged item is included (in millions)	Carrying Amount of the Hedged Assets/(Liabilities)				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of Hedged Assets/(Liabilities)
Balance sheet date as of	June 30, 2020		December 31, 2019		June 30, 2020		December 31, 2019
Interest Rate Contracts:
Long-Term Debt	$	—	$	(201)	$	—	$	(1)

Schedule of amount of gains and losses recognized in OCI and location and income statement location

Derivatives in Cash Flow	Gains (Losses) Recognized  in OCI on Derivatives				Income	Gains (Losses) Reclassified from AOCI into Income
Hedging Relationships	Three Months Ended June 30,				Statement	Three Months Ended June 30,
(in millions)	2020		2019		Location	2020		2019
Commodity contracts	$	(20)	$	10	Cost of sales	$	(17)	$	(5)
Foreign currency contracts		1		3	Net sales/Cost of sales		(1)		1
Interest rate contracts		(1)		—	Financing costs, net		(1)		—
Total	$	(20)	$	13		$	(19)	$	(4)

Derivatives in Cash-Flow	Gains (Losses) Recognized  in OCI on Derivatives				Income	Gains (Losses) Reclassified from AOCI into Income
Hedging Relationships	Six Months Ended June 30,				Statement	Six Months Ended June 30,
(in millions, pre-tax)	2020		2019		Location	2020		2019
Commodity contracts	$	(57)	$	—	Cost of sales	$	(24)	$	(3)
Foreign currency contracts		(4)		1	Net sales/Cost of sales		—		(2)
Interest rate contracts		(5)		—	Financing costs, net		(1)		(1)
Total	$	(66)	$	1		$	(25)	$	(6)

Schedule of location and amount of gain (loss) recognized in income

Derivatives in Fair Value Hedging	Income Statement Location of	Gains (Losses) Recognized in Income				Income Statement	Gains (Losses) Recognized in Income
Relationships	Derivatives Designated as	Three Months Ended June 30,				Location	Three Months Ended June 30,
(in millions)	Hedging Instruments	2020		2019		of Hedged Items	2020		2019
Interest rate contracts	Financing costs, net	$	(4)	$	3	Financing costs, net	$	4	$	(3)

Derivatives in Fair Value	Income Statement Location of	Gains (Losses) Recognized in Income				Income Statement	Gains (Losses) Recognized in Income
Hedging Relationships	Derivatives Designated as	Six Months Ended June 30,				Location	Six Months Ended June 30,
(in millions)	Hedging Instruments	2020		2019		of Hedged Items	2020		2019
Interest rate contracts	Financing costs, net	$	(1)	$	3	Financing costs, net	$	1	$	(3)

Schedule of fair value of financial instruments and derivatives

	As of June 30, 2020								As of December 31, 2019
(in millions)	Total		Level 1 (a)		Level 2 (b)		Level 3 (c)		Total		Level 1 (a)		Level 2 (b)		Level 3 (c)
Available for sale securities	$	10	$	10	$	—	$	—	$	13	$	13	$	—	$	—
Derivative assets		12		2		10		—		24		7		17		—
Derivative liabilities		53		21		32		—		36		5		31		—
Long-term debt		2,215		—		2,215		—		1,751		—		1,751		—

(a) Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities.

(b) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 2 inputs are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data.  

(c) Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

XML

Debt (Tables)

6 Months Ended

Jun. 30, 2020

Debt

Schedule of debt

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
2.900% senior notes due June 1, 2030	$	594	$	—
3.200% senior notes due October 1, 2026		497		497
3.900% senior notes due June 1, 2050		390		—
6.625% senior notes due April 15, 2037		253		253
4.625% senior notes due November 1, 2020		—		400
5.62% senior notes due March 25, 2020		—		200
Term loan credit agreement due April 12, 2021		405		405
Revolving credit facility		—		10
Other long-term borrowings		1		—
Fair value adjustment related to hedged fixed rate debt instruments		—		1
Long-term debt		2,140		1,766
4.625% senior notes due November 1, 2020		400		—
Other short-term borrowings		70		82
Short-term debt		470		82
Total debt	$	2,610	$	1,848

XML

Leases (Tables)

6 Months Ended

Jun. 30, 2020

Leases

Summary of components of lease expense

	Three Months Ended				Six Months Ended
Lease Cost	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Operating lease cost	$	13	$	14	$	26	$	27
Variable operating lease cost		7		6		15		12
Short term lease cost		1		1		2		1
Lease cost	$	21	$	21	$	43	$	40

Reconciliation of future undiscounted cash flows to the operating lease liabilities and the related ROU assets

Operating Leases		As of
(in millions)		June 30, 2020
2020 (Excluding the six months ended June 30, 2020)	$	26
2021		44
2022		35
2023		26
2024		18
Thereafter		34
Total future lease payments		183
Less imputed interest		27
Present value of future lease payments		156
Less current lease liabilities		41
Non-current operating lease liabilities	$	115
Operating lease assets	$	149

Summary of other lease information

	Three Months Ended				Six Months Ended
Other Information	June 30,				June 30,
($ in millions)	2020		2019		2020			2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	13	$	14	$	26		$	29
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases	$	13	$	6	$	21		$	167
					As of			As of
					June 30, 2020			December 31, 2019
Weighted average remaining lease term:
Operating leases						5.2 years			5.5 years
Weighted average discount rate:
Operating leases						5.5	%		5.7	%

XML

Net Periodic Pension and Postretirement Benefit Costs (Tables)

6 Months Ended

Jun. 30, 2020

Pension Plan

Pension and postretirement benefit plans

Components of net periodic benefit cost

	Three Months Ended June 30,								Six Months Ended June 30,
	U.S. Plans				Non-U.S. Plans				U.S. Plans				Non-U.S. Plans
(in millions)	2020		2019		2020		2019		2020		2019		2020		2019
Service cost	$	1	$	1	$	1	$	1	$	2	$	2	$	2	$	2
Interest cost		3		3		3		2		6		7		6		5
Expected return on plan assets		(6)		(4)		(2)		(2)		(11)		(9)		(4)		(4)
Amortization of actuarial loss		—		—		1		1		—		—		1		1
Net periodic benefit cost (a)	$	(2)	$	—	$	3	$	2	$	(3)	$	—	$	5	$	4

Postemployment Retirement Benefits

Pension and postretirement benefit plans

Components of net periodic benefit cost

	Three Months Ended June 30,				Six Months Ended June 30,
(in millions)	2020		2019		2020		2019
Service cost	$	—	$	—	$	—	$	—
Interest cost		1		—		2		1
Amortization of prior service credit		—		—		(1)		(1)
Net periodic benefit cost (a)	$	1	$	—	$	1	$	—

(a) The service cost component of net periodic benefit cost is presented within either cost of sales or operating expenses on the Condensed Consolidated Statements of Income. The interest cost, expected return on plan assets, amortization of prior service credit, and amortization of actuarial loss components of net periodic benefit cost are presented as other, non-operating income on the Condensed Consolidated Statements of Income.

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2020

Inventories

Components of inventories

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
Finished and in process	$	552	$	565
Raw materials		246		237
Manufacturing supplies and other		61		59
Total inventories	$	859	$	861

XML

Equity (Tables)

6 Months Ended

Jun. 30, 2020

Equity

Schedule of stock based compensation expense

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Stock options:
Pre-tax compensation expense	$	1	$	1	$	2	$	2
Income tax benefit		—		—		—		—
Stock option expense, net of income taxes		1		1		2		2
Restricted stock units ("RSUs"):
Pre-tax compensation expense		3		3		6		5
Income tax benefit		—		(1)		(1)		(1)
RSUs, net of income taxes		3		2		5		4
Performance shares and other share-based awards:
Pre-tax compensation expense		2		2		4		3
Income tax benefit		—		—		—		—
Performance shares and other share-based compensation expense, net of income taxes		2		2		4		3
Total share-based compensation:
Pre-tax compensation expense		6		6		12		10
Income tax benefit		—		(1)		(1)		(1)
Total share-based compensation expense, net of income taxes	$	6	$	5	$	11	$	9

Schedule of valuation assumptions for stock options

	Six Months Ended June 30,
	2020		2019
Expected life (in years)	5.5		5.5
Risk-free interest rate	1.4	%	2.5	%
Expected volatility	19.8	%	19.7	%
Expected dividend yield	2.9	%	2.7	%

Schedule of stock option transactions

	Number of Options (in thousands)	Weighted Average Exercise Price per Share		Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019	2,055	$	84.36	5.30	$	34
Granted	336		88.35
Exercised	(91)		45.01
Cancelled	(7)		81.09
Outstanding as of June 30, 2020	2,293	$	86.53	5.64	$	15
Exercisable as of June 30, 2020	1,742	$	84.05	4.58	$	15

Schedule of additional information pertaining to stock option activity

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(dollars in millions, except per share)	2020		2019		2020		2019
Weighted average grant date fair value of stock options granted (per share)	$	—	$	—	$	11.48	$	14.02
Total intrinsic value of stock options exercised	$	—	$	2	$	4	$	6

Schedule of restricted unit activity

(RSUs in thousands)	Number of Restricted Shares	Weighted Average Fair Value per Share
Non-vested as of December 31, 2019	339	$	108.02
Granted	171		88.29
Vested	(92)		117.25
Cancelled	(12)		104.34
Non-vested as of June 30, 2020	406	$	97.75

Summary of net changes in accumulated other comprehensive loss

(in millions)	Cumulative Translation Adjustment		Deferred (Loss) Gain on Hedging Activities		Pension and Postretirement Adjustment		Accumulated Other Comprehensive Loss
Balance, December 31, 2019	$	(1,089)	$	(9)	$	(60)	$	(1,158)
Other comprehensive loss before reclassification adjustments		(118)		(66)		—		(184)
Amount reclassified from accumulated OCI		—		25		—		25
Tax benefit		—		10		—		10
Net other comprehensive loss		(118)		(31)		—		(149)
Balance, June 30, 2020	$	(1,207)	$	(40)	$	(60)	$	(1,307)

(in millions)	Cumulative Translation Adjustment		Deferred (Loss) Gain on Hedging Activities		Pension and Postretirement Adjustment		Accumulated Other Comprehensive Loss
Balance, December 31, 2018	$	(1,080)	$	(5)	$	(69)	$	(1,154)
Other comprehensive income (loss) before reclassification adjustments		(3)		1		(1)		(3)
Amount reclassified from accumulated OCI		—		6		—		6
Tax provision		—		(1)		—		(1)
Net other comprehensive income (loss)		(3)		6		(1)		2
Balance, June 30, 2019	$	(1,083)	$	1	$	(70)	$	(1,152)

Schedule of stockholders equity and redeemable equity

	Total Equity														Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2019	$	—	$	1	$	1,137	$	(1,040)	$	(1,158)	$	3,780	$	21	$	31
Net income attributable to Ingredion												75
Net income attributable to non-controlling interests														3
Dividends declared, common stock ($0.63/share)												(42)
Share-based compensation, net of issuance						5		12								(8)
Other comprehensive loss										(164)				(3)
Balance, March 31, 2020	$	—	$	1	$	1,142	$	(1,028)	$	(1,322)	$	3,813	$	21	$	23
Net income attributable to Ingredion												66
Net income attributable to non-controlling interests														1
Dividends declared, common stock ($0.63/share)												(43)
Dividends declared, non-controlling interests														(3)
Share-based compensation, net of issuance						1		1								4
Other comprehensive income										15				1
Balance, June 30, 2020	$	—	$	1	$	1,143	$	(1,027)	$	(1,307)	$	3,836	$	20	$	27

	Total Equity														Share-based
					Additional				Accumulated Other				Non-		Payments
	Preferred		Common		Paid-In		Treasury		Comprehensive		Retained		Controlling		Subject to
(in millions)	Stock		Stock		Capital		Stock		Loss		Earnings		Interests		Redemption
Balance, December 31, 2018	$	—	$	1	$	1,096	$	(1,091)	$	(1,154)	$	3,536	$	20	$	37
Net income attributable to Ingredion												100
Net income attributable to non-controlling interests														2
Dividends declared, common stock ($0.625/share)												(42)
Repurchases of common stock						32		31
Share-based compensation, net of issuance						9		10								(16)
Other comprehensive loss										(6)
Balance, March 31, 2019	$	—	$	1	$	1,137	$	(1,050)	$	(1,160)	$	3,594	$	22	$	21
Net income attributable to Ingredion												105
Net income attributable to non-controlling interests														2
Dividends declared, common stock ($0.625/share)												(43)
Dividends declared, non-controlling interests														(4)
Share-based compensation, net of issuance						1		3								4
Other comprehensive income (loss)										8				(4)
Balance, June 30, 2019	$	—	$	1	$	1,138	$	(1,047)	$	(1,152)	$	3,656	$	16	$	25

Schedule of basic and diluted earnings per common share

	Three Months Ended June 30, 2020					Three Months Ended June 30, 2019
(in millions, except per share amounts)	Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount		Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount
Basic EPS	$	66	67.2	$	0.98	$	105	66.9	$	1.57
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards			0.4					0.5
Diluted EPS	$	66	67.6	$	0.98	$	105	67.4	$	1.56

	Six Months Ended June 30, 2020					Six Months Ended June 30, 2019
(in millions, except per share amounts)	Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount		Net Income Available to Ingredion		Weighted Average Shares	Per Share Amount
Basic EPS	$	141	67.2	$	2.10	$	205	66.9	$	3.06
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards			0.5					0.5
Diluted EPS	$	141	67.7	$	2.08	$	205	67.4	$	3.04

XML

Segment Information (Tables)

6 Months Ended

Jun. 30, 2020

Segment Information

Schedule of segment reporting of net sales, operating income and total assets

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Net sales to unaffiliated customers:
North America	$	848	$	977	$	1,811	$	1,928
South America		182		226		419		454
Asia-Pacific		187		203		376		406
EMEA		132		144		286		298
Total net sales	$	1,349	$	1,550	$	2,892	$	3,086

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in millions)	2020		2019		2020		2019
Operating income:
North America	$	101	$	139	$	226	$	264
South America		13		16		39		34
Asia-Pacific		22		23		42		43
EMEA		21		23		48		47
Corporate		(30)		(23)		(61)		(44)
Subtotal		127		178		294		344
Restructuring/impairment charges		(11)		(9)		(25)		(13)
Acquisition/integration costs		(3)		(1)		(3)		(2)
Total operating income	$	113	$	168	$	266	$	329

	As of		As of
(in millions)	June 30, 2020		December 31, 2019
Assets:
North America (a)	$	4,611	$	3,924
South America		647		774
Asia-Pacific		838		843
EMEA		515		499
Total assets	$	6,611	$	6,040

(a) For purposes of presentation, North America includes Corporate assets.

XML

Summary of Significant Accounting Standards and Policies - ASUs (Details)	Jan. 01, 2020
ASU 2017-04,Intangibles - Goodwill and Other
Recently Adopted Accounting Standards
Change in Accounting Principle, Accounting Standards Update, Adopted	true
AUS 2016-13, Financial Instruments - Credit Losses
Recently Adopted Accounting Standards
Change in Accounting Principle, Accounting Standards Update, Adopted	true

XML

Summary of Significant Accounting Standards and Policies - Net Sales (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Disaggregation of revenue
Net sales	$ 1,349	$ 1,550	$ 2,892	$ 3,086
Cost of sales	1,078	1,221	2,298	2,441
Gross profit	$ 271	329	$ 594	645
North America
Disaggregation of revenue
Net sales		977		1,928
South America
Disaggregation of revenue
Net sales		226		454
Asia-Pacific
Disaggregation of revenue
Net sales		203		406
EMEA
Disaggregation of revenue
Net sales		144		298
Change In Presentation, Shipping and Handling Costs | As Previously Reported
Disaggregation of revenue
Net sales before shipping and handling costs		1,550		3,086
Less: shipping and handling costs		116		232
Net sales		1,434		2,854
Cost of sales		1,105		2,209
Gross profit		329		645
Change In Presentation, Shipping and Handling Costs | As Previously Reported | North America
Disaggregation of revenue
Net sales		885		1,745
Change In Presentation, Shipping and Handling Costs | As Previously Reported | South America
Disaggregation of revenue
Net sales		215		433
Change In Presentation, Shipping and Handling Costs | As Previously Reported | Asia-Pacific
Disaggregation of revenue
Net sales		195		389
Change In Presentation, Shipping and Handling Costs | As Previously Reported | EMEA
Disaggregation of revenue
Net sales		$ 139		$ 287

XML

Acquisitions (Details) - USD ($) $ in Millions		6 Months Ended
	Mar. 01, 2019	Jun. 30, 2019	Jun. 30, 2020	Dec. 31, 2019
Acquisitions
Payment for acquisition, net of cash acquired		$ 42
Cash acquired from acquisition		$ 4
Goodwill			$ 791	$ 801
Western Polymer
Acquisitions
Payment for acquisition, net of cash acquired	$ 42
Cash acquired from acquisition	4
Goodwill	13
Tangible assets, net	$ 29

XML

Revenue Recognition (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($) segment	Jun. 30, 2019 USD ($)
Disaggregation of revenue
Revenue, practical expedient, incremental cost of obtaining contract			true
Number of reportable business segments | segment			4
Total net sales	$ 1,349	$ 1,550	$ 2,892	$ 3,086
North America
Disaggregation of revenue
Total net sales	848	977	1,811	1,928
South America
Disaggregation of revenue
Total net sales	182	226	419	454
Asia-Pacific
Disaggregation of revenue
Total net sales	187	203	376	406
EMEA
Disaggregation of revenue
Total net sales	$ 132	$ 144	$ 286	$ 298

XML

Restructuring and Impairment Charges - Charges (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2020	Jun. 30, 2020	Jun. 30, 2019
Restructuring and impairment charges
Restructuring charges		$ 9			$ 13
Cost Smart cost of sales and SG&A Program
Restructuring and impairment charges
Restructuring charges	$ 11			$ 25
Cost Smart cost of sales and SG&A Program | Employee-related severance costs
Restructuring and impairment charges
Restructuring charges				3
Cost Smart Cost of Sales Program
Restructuring and impairment charges
Restructuring charges	6	3		15	4
Cost Smart Cost of Sales Program | Cessation of wet-milling
Restructuring and impairment charges
Restructuring charges		1			2
Cost Smart Cost of Sales Program, Production facility closure, Australia | Forecast
Restructuring and impairment charges
Restructuring charges			$ 2
Cost Smart Cost of Sales Program, Production facility closure, Australia | Asset write-off
Restructuring and impairment charges
Restructuring charges	3			6
Cost Smart Cost of Sales Program, Production facility closure, Australia | Accelerated depreciation
Restructuring and impairment charges
Restructuring charges				1
Cost Smart Cost of Sales Program, Production facility closure, Australia | Other restructuring costs
Restructuring and impairment charges
Restructuring charges	1			2
Cost Smart Cost of Sales Program, North America | Accelerated depreciation
Restructuring and impairment charges
Restructuring charges	1			4
Cost Smart Cost of Sales Program, North America | Employee-related severance costs
Restructuring and impairment charges
Restructuring charges	1			1
Cost Smart Cost of Sales Program, North America | Other restructuring costs
Restructuring and impairment charges
Restructuring charges				1
Cost Smart SG&A Program
Restructuring and impairment charges
Restructuring charges	5			10
Cost Smart SG&A Program | Employee-related severance costs
Restructuring and impairment charges
Restructuring charges				2
Cost Smart SG&A Program | Employee-related severance and other costs
Restructuring and impairment charges
Restructuring charges		6			9
Cost Smart SG&A Program | Other restructuring costs
Restructuring and impairment charges
Restructuring charges				$ 8
Cost Smart SG&A Program, Latin American Finance Transformation Initiative | Other restructuring costs
Restructuring and impairment charges
Restructuring charges		$ 1			$ 2
Cost Smart SG&A Program, North America
Restructuring and impairment charges
Restructuring charges	$ 5

XML

Restructuring and Impairment Charges - Employee-related severance (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restructuring accrual
Restructuring charges		$ 9		$ 13
Employee-related severance costs
Restructuring accrual
Balance in severance accrual at beginning of period			$ 15
Payments made to terminated employees			(9)
Foreign exchange translation			(1)
Balance in severance accrual at end of period	$ 8		8
Restructuring reserve, Expected to be paid in next 12 months	7		7
Cost Smart cost of sales and SG&A Program
Restructuring accrual
Restructuring charges	$ 11		25
Cost Smart cost of sales and SG&A Program | Employee-related severance costs
Restructuring accrual
Restructuring charges			$ 3

XML

Restructuring and Impairment Charges - Other assets (Details) $ in Millions	Jun. 30, 2020 USD ($)
Other assets
Restructuring and impairment charges
Assets held for sale	$ 13

XML

Financial Instruments, Derivatives and Hedging Activities - Commodity price hedging (Details) bu in Millions, MMBTU in Millions	6 Months Ended
	Jun. 30, 2020 MMBTU bu
Commodity Contracts | Minimum
Financial instruments, derivatives and hedging activities
Maturity period of price risk derivative	12 months
Commodity Contracts | Maximum
Financial instruments, derivatives and hedging activities
Maturity period of price risk derivative	24 months
Corn Commodity
Financial instruments, derivatives and hedging activities
Futures contract (in bushels for corn and gallons for ethanol) | bu	64
Natural Gas Commodity
Financial instruments, derivatives and hedging activities
Natural gas futures contract (in mmbtu) | MMBTU	33

XML

Financial Instruments, Derivatives and Hedging Activities - Foreign currency hedging (Details) - Foreign Currency Forward Contracts - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Short | Not Designated as Hedging Instrument
Financial instruments, derivatives and hedging activities
Derivative notional amount	$ 590	$ 621
Long | Not Designated as Hedging Instrument
Financial instruments, derivatives and hedging activities
Derivative notional amount	478	356
Cash Flow Hedging | Short | Designated as Hedging Instrument
Financial instruments, derivatives and hedging activities
Derivative notional amount	325	374
Cash Flow Hedging | Long | Designated as Hedging Instrument
Financial instruments, derivatives and hedging activities
Derivative notional amount	$ 460	$ 541

XML

Financial Instruments, Derivatives and Hedging Activities - Interest rate hedging (Details) - 4.625% senior notes due November 1, 2020 $ in Millions	Dec. 31, 2019 USD ($)
Financial instruments, derivatives and hedging activities
Principal amount	$ 400
Fair Value Hedging | Interest Rate Swap
Financial instruments, derivatives and hedging activities
Principal amount	$ 200
Debt, fixed interest rate (as a percent)	4.625%

XML

Financial Instruments, Derivatives and Hedging Activities - CF Hedges in AOCI (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	$ (1,307)	$ (1,158)
Cash Flow Hedging
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	(40)	(9)
Cash Flow Hedging | Commodity Contracts
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	(36)	(11)
Tax effect on gains (losses) of derivative instruments	13	5
Cash Flow Hedging | Foreign Currency Contracts
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)		3
Tax effect on gains (losses) of derivative instruments		(1)
Cash Flow Hedging | Interest Rate Contracts
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	(4)	$ (1)
Tax effect on gains (losses) of derivative instruments	$ 1

XML

Financial Instruments, Derivatives and Hedging Activities - Balance Sheet Location (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Designated as Hedging Instrument
Fair value of derivatives
Fair value of derivative instruments, Assets	$ 6	$ 17
Fair value of derivative instruments, Liabilities	30	25
Fair value of derivative instruments, Net Assets/(Liabilities)	(24)	(8)
Designated as Hedging Instrument | Accounts receivable, net
Fair value of derivatives
Fair value of derivative instruments, Assets	3	12
Designated as Hedging Instrument | Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	3	5
Designated as Hedging Instrument | Accounts payable and accrued liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	28	17
Designated as Hedging Instrument | Non-current liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	2	8
Designated as Hedging Instrument | Commodity Contracts
Fair value of derivatives
Fair value of derivative instruments, Assets	5	6
Fair value of derivative instruments, Liabilities	28	17
Fair value of derivative instruments, Net Assets/(Liabilities)	(23)	(11)
Designated as Hedging Instrument | Commodity Contracts | Accounts receivable, net
Fair value of derivatives
Fair value of derivative instruments, Assets	3	5
Designated as Hedging Instrument | Commodity Contracts | Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	2	1
Designated as Hedging Instrument | Commodity Contracts | Accounts payable and accrued liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	26	13
Designated as Hedging Instrument | Commodity Contracts | Non-current liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	2	4
Designated as Hedging Instrument | Foreign Currency Forward Contracts
Fair value of derivatives
Fair value of derivative instruments, Assets	1	10
Fair value of derivative instruments, Liabilities	2	8
Fair value of derivative instruments, Net Assets/(Liabilities)	(1)	2
Designated as Hedging Instrument | Foreign Currency Forward Contracts | Accounts receivable, net
Fair value of derivatives
Fair value of derivative instruments, Assets		7
Designated as Hedging Instrument | Foreign Currency Forward Contracts | Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	1	3
Designated as Hedging Instrument | Foreign Currency Forward Contracts | Accounts payable and accrued liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	2	4
Designated as Hedging Instrument | Foreign Currency Forward Contracts | Non-current liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities		4
Designated as Hedging Instrument | Interest Rate Contracts
Fair value of derivatives
Fair value of derivative instruments, Assets		1
Fair value of derivative instruments, Net Assets/(Liabilities)		1
Designated as Hedging Instrument | Interest Rate Contracts | Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets		1
Not Designated as Hedging Instrument
Fair value of derivatives
Fair value of derivative instruments, Assets	6	7
Fair value of derivative instruments, Liabilities	23	11
Fair value of derivative instruments, Net Assets/(Liabilities)	(17)	(4)
Not Designated as Hedging Instrument | Accounts receivable, net
Fair value of derivatives
Fair value of derivative instruments, Assets	5	6
Not Designated as Hedging Instrument | Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	1	1
Not Designated as Hedging Instrument | Accounts payable and accrued liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	20	9
Not Designated as Hedging Instrument | Non-current liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	3	2
Not Designated as Hedging Instrument | Commodity Contracts
Fair value of derivatives
Fair value of derivative instruments, Assets		2
Fair value of derivative instruments, Liabilities	4	1
Fair value of derivative instruments, Net Assets/(Liabilities)	(4)	1
Not Designated as Hedging Instrument | Commodity Contracts | Accounts receivable, net
Fair value of derivatives
Fair value of derivative instruments, Assets		2
Not Designated as Hedging Instrument | Commodity Contracts | Accounts payable and accrued liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	4	1
Not Designated as Hedging Instrument | Foreign Currency Forward Contracts
Fair value of derivatives
Fair value of derivative instruments, Assets	6	5
Fair value of derivative instruments, Liabilities	19	10
Fair value of derivative instruments, Net Assets/(Liabilities)	(13)	(5)
Not Designated as Hedging Instrument | Foreign Currency Forward Contracts | Accounts receivable, net
Fair value of derivatives
Fair value of derivative instruments, Assets	5	4
Not Designated as Hedging Instrument | Foreign Currency Forward Contracts | Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	1	1
Not Designated as Hedging Instrument | Foreign Currency Forward Contracts | Accounts payable and accrued liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	16	8
Not Designated as Hedging Instrument | Foreign Currency Forward Contracts | Non-current liabilities
Fair value of derivatives
Fair value of derivative instruments, Liabilities	$ 3	$ 2

XML

Financial Instruments, Derivatives and Hedging Activities - Additional information - FV hedges (Details) - Fair Value Hedging - Long-term debt $ in Millions	Dec. 31, 2019 USD ($)
Additional information pertaining to fair value hedges
Carrying Amount of the Hedged Liabilities	$ (201)
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of Hedged Liabilities	$ (1)

XML

Financial Instruments, Derivatives and Hedging Activities - Additional information - CF hedges (Details) - Cash Flow Hedging - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Hedging relationships
Gains (Losses) Recognized in OCI	$ (20)	$ 13	$ (66)	$ 1
Gains (Losses) Reclassified from AOCI into Income	(19)	(4)	(25)	(6)
Commodity Contracts
Hedging relationships
Gains (Losses) Recognized in OCI	(20)	10	(57)
Commodity Contracts | Cost of sales
Hedging relationships
Gains (Losses) Reclassified from AOCI into Income	(17)	(5)	(24)	(3)
Foreign Currency Contracts
Hedging relationships
Gains (Losses) Recognized in OCI	1	3	(4)	1
Foreign Currency Contracts | Net sales/Cost of sales
Hedging relationships
Gains (Losses) Reclassified from AOCI into Income	(1)	$ 1		(2)
Interest Rate Contracts
Hedging relationships
Gains (Losses) Recognized in OCI	(1)		(5)
Interest Rate Contracts | Financing costs, net
Hedging relationships
Gains (Losses) Reclassified from AOCI into Income	$ (1)		$ (1)	$ (1)

XML

Financial Instruments, Derivatives and Hedging Activities - Gain (Losses) Recognized in Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Hedging relationships
Loss expected to be reclassified into earnings during the next twelve months, net of tax			$ (36)
Loss expected to be reclassified into earnings during the next twelve months, income tax effect			13
Fair Value Hedging | Interest Rate Contracts | Financing costs, net
Hedging relationships
Gains (losses) recognized in income, Hedging instruments	$ (4)	$ 3	(1)	$ 3
Gains (losses) recognized in income, Hedged item	$ 4	$ (3)	$ 1	$ (3)

XML

Financial Instruments, Derivatives and Hedging Activities - FV (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Carrying value
Fair value of assets and liabilities
Long-term debt	$ 2,100
Fair value
Fair value of assets and liabilities
Long-term debt	2,200
Fair Value, Measurements, Recurring
Fair value of assets and liabilities
Available for sale securities	10	$ 13
Derivative assets	12	24
Derivative liabilities	53	36
Long-term debt	2,215	1,751
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1
Fair value of assets and liabilities
Available for sale securities	10	13
Derivative assets	2	7
Derivative liabilities	21	5
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Fair value of assets and liabilities
Derivative assets	10	17
Derivative liabilities	32	31
Long-term debt	$ 2,215	$ 1,751

XML

Debt - Components (Details) - USD ($) $ in Millions	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Financing Arrangements
Other long-term borrowings	$ 1
Fair value adjustment related to hedged fixed rate debt instruments			$ 1
Long-term debt	2,140		1,766
Other short-term borrowings	70		82
Short-term debt	470		82
Total debt	$ 2,610		$ 1,848
2.9% senior notes due June 1, 2030
Financing Arrangements
Debt, interest rate (as a percent)	2.90%
Long-term debt excluding fair value adjustments	$ 594
3.2% senior notes due October 1, 2026
Financing Arrangements
Debt, interest rate (as a percent)	3.20%		3.20%
Long-term debt excluding fair value adjustments	$ 497		$ 497
3.9% senior notes due June 1, 2050
Financing Arrangements
Debt, interest rate (as a percent)	3.90%
Long-term debt excluding fair value adjustments	$ 390
6.625% senior notes due April 15, 2037
Financing Arrangements
Debt, interest rate (as a percent)	6.625%		6.625%
Long-term debt excluding fair value adjustments	$ 253		$ 253
4.625% senior notes due November 1, 2020
Financing Arrangements
Debt, interest rate (as a percent)	4.625%		4.625%
Long-term debt excluding fair value adjustments			$ 400
Short term borrowings	$ 400
5.62% senior notes due March 25, 2020
Financing Arrangements
Debt, interest rate (as a percent)		5.62%	5.62%
Long-term debt excluding fair value adjustments			$ 200
Term loan credit agreement due April 12, 2021
Financing Arrangements
Long-term debt excluding fair value adjustments	$ 405		405
Revolving credit facility
Financing Arrangements
Long-term debt excluding fair value adjustments			$ 10

XML

Debt - Additional information (Details) - USD ($) $ in Millions		3 Months Ended
	Jul. 09, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
2.9% senior notes due June 1, 2030 and 3.9% senior notes due June 1, 2050
Financing Arrangements
Discount		$ 7
Debt issuance costs capitalized		$ 9
2.9% senior notes due June 1, 2030
Financing Arrangements
Debt, interest rate (as a percent)		2.90%
Principal amount		$ 600
3.9% senior notes due June 1, 2050
Financing Arrangements
Debt, interest rate (as a percent)		3.90%
Principal amount		$ 400
Revolving credit facility
Financing Arrangements
Repayments of long-term debt		$ 394
4.625% senior notes due November 1, 2020
Financing Arrangements
Debt, interest rate (as a percent)		4.625%		4.625%
Principal amount				$ 400
Debt balance		$ 400
4.625% senior notes due November 1, 2020 | Subsequent Event.
Financing Arrangements
Amount of debt redeemed	$ 400
Debt redemption price	$ 409
5.62% senior notes due March 25, 2020
Financing Arrangements
Repayments of long-term debt			$ 200
Debt, interest rate (as a percent)			5.62%	5.62%

XML

Leases - Lease costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Leases
Finance lease liability	$ 0		$ 0
Lease Cost
Operating lease cost	13	$ 14	26	$ 27
Variable operating lease cost	7	6	15	12
Short term lease cost	1	1	2	1
Lease cost	$ 21	$ 21	$ 43	$ 40

XML

Leases - Operating lease reconciliation (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Reconciliation of future undiscounted cash flows to the operating lease liabilities and the related ROU assets
2020 (Excluding the six months ended June 30, 2020)	$ 26
2021	44
2022	35
2023	26
2024	18
Thereafter	34
Total future lease payments	183
Less imputed interest	27
Present value of future lease payments	156
Less current lease liabilities	41
Non-current operating lease liabilities	115	$ 120
Operating lease assets	$ 149	$ 151

XML

Leases - Other Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Other information
Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases	$ 13	$ 14	$ 26	$ 29
Right-of-use assets obtained in exchange for lease liabilities: Operating leases	$ 13	$ 6	$ 21	$ 167
Weighted average remaining lease term (years): Operating leases	5 years 2 months 12 days		5 years 2 months 12 days		5 years 6 months
Weighted average discount rate: Operating leases	5.50%		5.50%		5.70%

XML

Taxes - Effective tax rate (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Taxes
Effective tax rate (as a percent)	28.70%	29.60%	37.00%	28.20%
Devaluation of Mexican peso against U.S. dollar (as a percent)			22.00%
Discrete tax expense (benefit) due to taxable translation gains on net U.S. dollar monetary assets held in Mexico			$ 22	$ 1

XML

Net Periodic Pension and Postretirement Benefit Costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Non-US
Employer contributions
Employer contributions			$ 1
Pension Plan
Anticipated cash contributions
Anticipated cash contributions in current year	$ 4		4
Pension Plan | US
Components of Net Periodic Benefit Costs
Service cost	1	$ 1	2	$ 2
Interest cost	3	3	6	7
Expected return on plan assets	(6)	(4)	(11)	(9)
Net periodic benefit cost/(benefit)	(2)		(3)
Anticipated cash contributions
Anticipated cash contributions in current year	1		1
Pension Plan | Non-US
Components of Net Periodic Benefit Costs
Service cost	1	1	2	2
Interest cost	3	2	6	5
Expected return on plan assets	(2)	(2)	(4)	(4)
Amortization of actuarial loss	1	1	1	1
Net periodic benefit cost/(benefit)	3	$ 2	5	4
Anticipated cash contributions
Anticipated cash contributions in current year	3		3
Postemployment Retirement Benefits
Components of Net Periodic Benefit Costs
Interest cost	1		2	1
Amortization of prior service credit			(1)	$ (1)
Net periodic benefit cost/(benefit)	$ 1		$ 1

XML

Inventories (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Inventories
Finished and in process	$ 552	$ 565
Raw materials	246	237
Manufacturing supplies and other	61	59
Total inventories	$ 859	$ 861

XML

Equity - Treasury stock (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended				6 Months Ended
	Feb. 06, 2019	Nov. 05, 2018	Jun. 30, 2020	Mar. 31, 2019	Feb. 06, 2019	Feb. 05, 2019	Jun. 30, 2020	Jun. 30, 2019	Oct. 22, 2018
Treasury stock:
Purchase/acquisition of treasury stock (in shares)			0				0
Additional Paid-in Capital
Treasury stock:
Repurchases of common stock, net				$ 32				$ 32
Treasury Stock
Treasury stock:
Repurchases of common stock, net				$ 31				$ 31
ASR agreement
Treasury stock:
Payment made for repurchase of shares		$ 455
Purchase/acquisition of treasury stock (in shares)		4,000,000				4,000,000
Repurchases of common stock, net		$ (423)			$ (392)
VWAP (in dollars per share)						$ 98.04
Amount of cash returned from upfront payment in repurchase of stock	$ 63
2018 Stock Repurchase Program
Treasury stock:
Shares authorized to be repurchased (in shares)									8,000,000

XML

Equity - Share-based payments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Share-based compensation expense
Pre-tax compensation expense	$ 6	$ 6	$ 12	$ 10
Income tax benefit		(1)	(1)	(1)
Total share-based compensation expense, net of income taxes	6	5	11	9
Stock options
Share-based compensation expense
Pre-tax compensation expense	1	1	2	2
Total share-based compensation expense, net of income taxes	1	1	2	2
Restricted stock units (RSUs)
Share-based compensation expense
Pre-tax compensation expense	3	3	6	5
Income tax benefit		(1)	(1)	(1)
Total share-based compensation expense, net of income taxes	3	2	5	4
Performance shares and other share-based awards
Share-based compensation expense
Pre-tax compensation expense	2	2	4	3
Total share-based compensation expense, net of income taxes	$ 2	$ 2	$ 4	$ 3

XML

Equity - Stock options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Stock options, Number of Options
Outstanding at the beginning of the period (in shares)		2,055
Granted (in shares)		336	247
Exercised (in shares)		(91)
Cancelled (in shares)		(7)
Outstanding at the end of the period (in shares)		2,293		2,055
Exercisable at the end of the period (in shares)		1,742
Stock options, Weighted Average Exercise Price per Share
Outstanding at the beginning of the period (in dollars per share)		$ 84.36
Granted (in dollars per share)		88.35
Exercised (in dollars per share)		45.01
Cancelled (in dollars per share)		81.09
Outstanding at the end of the period (in dollars per share)		86.53		$ 84.36
Exercisable at the end of the period (in dollars per share)		$ 84.05
Additional information pertaining to stock options
Average Remaining Contractual Term, Outstanding		5 years 7 months 20 days		5 years 3 months 18 days
Average Remaining Contractual Term, Exercisable		4 years 6 months 29 days
Aggregate Intrinsic Value, Outstanding (in dollars)		$ 15		$ 34
Aggregate Intrinsic Value, Exercisable (in dollars)		15
Cash received from exercise of stock options		$ 5
Weighted average grant date fair value of stock options granted (per share)		$ 11.48	$ 14.02
Total intrinsic value of stock options exercised	$ 2	$ 4	$ 6
Stock options
Share-based compensation
Term of award		10 years
Period of vesting		3 years
Required service period		1 year
Assumptions used to measure the fair value of awards
Expected life		5 years 6 months	5 years 6 months
Risk-free interest rate (as a percent)		1.40%	2.50%
Expected volatility (as a percent)		19.80%	19.70%
Expected dividend yield (as a percent)		2.90%	2.70%
Additional information pertaining to stock options
Unrecognized compensation cost		$ 4
Weighted-average period for amortization of unrecognized compensation cost		1 year 8 months 12 days

XML

Equity - Restricted stock units (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
Other disclosures
Share-based payments subject to redemption	$ 27	$ 23	$ 31	$ 25	$ 21	$ 37
Restricted stock units (RSUs)
Share-based compensation
Vesting terms	3 years
Service period over which compensation expense would be amortized	1 year
Restricted stock unit activity
Non-vested at the beginning of the period (in shares)	339
Granted (in shares)	171
Vested (in shares)	(92)
Cancelled (in shares)	(12)
Non-vested at the end of the period (in shares)	406
Weighted-average fair value per share
Non-vested at the beginning of the period (in dollars per share)	$ 108.02
Granted (in dollars per share)	88.29
Vested (in dollars per share)	117.25
Cancelled (in dollars per share)	104.34
Non-vested at the end of the period (in dollars per share)	$ 97.75
Other disclosures
Unrecognized compensation cost	$ 21
Weighted-average period for amortization of unrecognized compensation cost	2 years

XML

Equity - Performance shares (Details) $ / shares in Units, shares in Thousands, $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2020 USD ($) item $ / shares shares	Dec. 31, 2018 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)
Share-based compensation
Share-based payments subject to redemption | $	$ 27.0	$ 37.0	$ 23.0	$ 31.0	$ 25.0	$ 21.0
Performance Shares
Share-based compensation
Number of tranches | item	2
Vesting terms		3 years
Granted (in shares) | shares	81
Weighted-average fair value per share, Granted (in dollars per share) | $ / shares	$ 94.48
Unrecognized compensation cost | $	$ 8.0
Remaining requisite service period (in years)	2 years 2 months 12 days
Cancelled (in shares) | shares	0
Market-based performance shares
Share-based compensation
Percentage of share-based compensation award	50.00%
Performance shares calculation period (in years)	3 years
Vesting terms	3 years
Market-based performance shares | Minimum
Share-based compensation
Performance shares available for vesting (as a percent)	0.00%
Market-based performance shares | Maximum
Share-based compensation
Performance shares available for vesting (as a percent)	200.00%
Internal-based performance based
Share-based compensation
Percentage of share-based compensation award	50.00%
Performance shares calculation period (in years)	3 years
Vesting terms	3 years
Internal-based performance based | Minimum
Share-based compensation
Performance shares available for vesting (as a percent)	0.00%
Internal-based performance based | Maximum
Share-based compensation
Performance shares available for vesting (as a percent)	200.00%
Performance Shares Award Granted in 2017
Share-based compensation
Award pay out achieved (as a percent)	0.00%

XML

Equity - AOCI (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	$ 2,720
Balance at the end of the period	2,646
Cumulative Translation Adjustment
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	(1,089)	$ (1,080)
Other comprehensive income (loss) before reclassification adjustments	(118)	(3)
Net other comprehensive income (loss)	(118)	(3)
Balance at the end of the period	(1,207)	(1,083)
(Loss) Gain on Hedging Activities
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	(9)	(5)
Other comprehensive income (loss) before reclassification adjustments	(66)	1
Amount reclassified from accumulated OCI	25	6
Tax benefit (provision)	10	(1)
Net other comprehensive income (loss)	(31)	6
Balance at the end of the period	(40)	1
Pension and other postretirement plans
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	(60)	(69)
Other comprehensive income (loss) before reclassification adjustments		(1)
Net other comprehensive income (loss)		(1)
Balance at the end of the period	(60)	(70)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	(1,158)	(1,154)
Other comprehensive income (loss) before reclassification adjustments	(184)	(3)
Amount reclassified from accumulated OCI	25	6
Tax benefit (provision)	10	(1)
Net other comprehensive income (loss)	(149)	2
Balance at the end of the period	$ (1,307)	$ (1,152)

XML

Equity - Statements of Equity with dividends per share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Balance		$ 2,741			$ 2,741
Net income	$ 67		$ 107		145	$ 209
Balance	$ 2,666				2,666
Dividends declared, common stock (in dollars per share)	$ 0.63	$ 0.63	$ 0.625	$ 0.625
Common Stock
Balance	$ 1	$ 1	$ 1	$ 1	1	1
Balance	1	1	1	1	1	1
Additional Paid-in Capital
Balance	1,142	1,137	1,137	1,096	1,137	1,096
Repurchases of common stock, net				32		32
Share-based compensation, net of issuance	1	5	1	9	6	10
Balance	1,143	1,142	1,138	1,137	1,143	1,138
Treasury Stock
Balance	(1,028)	(1,040)	(1,050)	(1,091)	(1,040)	(1,091)
Repurchases of common stock, net				31		31
Share-based compensation, net of issuance	1	12	3	10	13	13
Balance	(1,027)	(1,028)	(1,047)	(1,050)	(1,027)	(1,047)
Accumulated Other Comprehensive Loss
Balance	(1,322)	(1,158)	(1,160)	(1,154)	(1,158)	(1,154)
Other comprehensive income (loss)	15	(164)	8	(6)	(149)	2
Balance	(1,307)	(1,322)	(1,152)	(1,160)	(1,307)	(1,152)
Retained Earnings
Balance	3,813	3,780	3,594	3,536	3,780	3,536
Net income	66	75	105	100	141	205
Dividends declared, common stock	(43)	(42)	(43)	(42)	(85)	(85)
Balance	3,836	3,813	3,656	3,594	3,836	3,656
Non-Controlling Interests
Balance	21	21	22	20	21	20
Net income	1	3	2	2	4	4
Dividends declared, common stock	(3)		(4)		(3)	(4)
Other comprehensive income (loss)	1	(3)	(4)		(2)	(4)
Balance	$ 20	$ 21	$ 16	$ 22	$ 20	$ 16

XML

Equity - Statements of Redeemable Equity (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Share-based Payments Subject to Redemption
Beginning Balance	$ 23	$ 31	$ 21	$ 37	$ 31	$ 37
Share-based compensation, net of issuance	4	(8)	4	(16)	(4)	(12)
Ending Balance	$ 27	$ 23	$ 25	$ 21	$ 27	$ 25

XML

Equity - EPS (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Basic EPS:
Net Income Available to Ingredion - basic	$ 66	$ 105	$ 141	$ 205
Weighted average number of shares outstanding, basic	67.2	66.9	67.2	66.9
Basic earnings per common share of Ingredion (in dollars per share)	$ 0.98	$ 1.57	$ 2.10	$ 3.06
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards	0.4	0.5	0.5	0.5
Diluted EPS:
Net Income Available to Ingredion - diluted	$ 66	$ 105	$ 141	$ 205
Weighted Average Number of Shares Outstanding, Diluted, Total	67.6	67.4	67.7	67.4
Diluted earnings per common share of Ingredion (in dollars per share)	$ 0.98	$ 1.56	$ 2.08	$ 3.04
Antidilutive securities excluded in calculation of diluted EPS:
Antidilutive securities excluded from computation of earnings per share amount	1.6	1.0	1.3	1.0

XML

Segment Information - Net sales (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($) segment	Jun. 30, 2019 USD ($)
Segment information
Number of reportable business segments | segment			4
Total net sales	$ 1,349	$ 1,550	$ 2,892	$ 3,086
Operating income Subtotal	127	178	294	344
Restructuring/impairment charges	(11)	(9)	(25)	(13)
Acquisition / integration costs	(3)	(1)	(3)	(2)
Operating income	113	168	266	329
North America
Segment information
Total net sales	848	977	1,811	1,928
South America
Segment information
Total net sales	182	226	419	454
Asia-Pacific
Segment information
Total net sales	187	203	376	406
EMEA
Segment information
Total net sales	132	144	286	298
Operating Segments | North America
Segment information
Operating income Subtotal	101	139	226	264
Operating Segments | South America
Segment information
Operating income Subtotal	13	16	39	34
Operating Segments | Asia-Pacific
Segment information
Operating income Subtotal	22	23	42	43
Operating Segments | EMEA
Segment information
Operating income Subtotal	21	23	48	47
Corporate, Non -Segment
Segment information
Operating income Subtotal	$ (30)	$ (23)	$ (61)	$ (44)

XML

Segment Information - Assets (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Segment information
Total assets	$ 6,611	$ 6,040
North America
Segment information
Total assets	4,611	3,924
South America
Segment information
Total assets	647	774
Asia-Pacific
Segment information
Total assets	838	843
EMEA
Segment information
Total assets	$ 515	$ 499

XML

Subsequent Events (Details) - Subsequent Event. $ in Millions	Jul. 01, 2020 USD ($)
Ingredion SRSS
Subsequent Event
Ownership percentage	75.00%
Ingredion SRSS | Former PureCircle Shareholders
Subsequent Event
Ownership percentage	25.00%
PureCircle Limited
Subsequent Event
Purchase price	$ 222